<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1990-04-01" modified="2020-10-07" version="224">
<accession>P15941</accession>
<accession>A5YRV1</accession>
<accession>A6ZID9</accession>
<accession>A6ZIE0</accession>
<accession>B1AVQ8</accession>
<accession>B1AVR0</accession>
<accession>B6ECA1</accession>
<accession>E7ESE5</accession>
<accession>E7EUG9</accession>
<accession>P13931</accession>
<accession>P15942</accession>
<accession>P17626</accession>
<accession>Q0VAP5</accession>
<accession>Q0VAP6</accession>
<accession>Q14128</accession>
<accession>Q14876</accession>
<accession>Q16437</accession>
<accession>Q16442</accession>
<accession>Q16615</accession>
<accession>Q6S4Y3</accession>
<accession>Q7Z547</accession>
<accession>Q7Z548</accession>
<accession>Q7Z550</accession>
<accession>Q7Z552</accession>
<accession>Q9BXA4</accession>
<accession>Q9UE75</accession>
<accession>Q9UE76</accession>
<accession>Q9UQL1</accession>
<accession>Q9Y4J2</accession>
<name>MUC1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Mucin-1</fullName>
<shortName>MUC-1</shortName>
</recommendedName>
<alternativeName>
<fullName>Breast carcinoma-associated antigen DF3</fullName>
</alternativeName>
<alternativeName>
<fullName>Cancer antigen 15-3</fullName>
<shortName>CA 15-3</shortName>
</alternativeName>
<alternativeName>
<fullName>Carcinoma-associated mucin</fullName>
</alternativeName>
<alternativeName>
<fullName>Episialin</fullName>
</alternativeName>
<alternativeName>
<fullName>H23AG</fullName>
</alternativeName>
<alternativeName>
<fullName>Krebs von den Lungen-6</fullName>
<shortName>KL-6</shortName>
</alternativeName>
<alternativeName>
<fullName>PEMT</fullName>
</alternativeName>
<alternativeName>
<fullName>Peanut-reactive urinary mucin</fullName>
<shortName>PUM</shortName>
</alternativeName>
<alternativeName>
<fullName>Polymorphic epithelial mucin</fullName>
<shortName>PEM</shortName>
</alternativeName>
<alternativeName>
<fullName>Tumor-associated epithelial membrane antigen</fullName>
<shortName>EMA</shortName>
</alternativeName>
<alternativeName>
<fullName>Tumor-associated mucin</fullName>
</alternativeName>
<cdAntigenName>CD227</cdAntigenName>
<component>
<recommendedName>
<fullName>Mucin-1 subunit alpha</fullName>
<shortName>MUC1-NT</shortName>
<shortName>MUC1-alpha</shortName>
</recommendedName>
</component>
<component>
<recommendedName>
<fullName>Mucin-1 subunit beta</fullName>
<shortName>MUC1-beta</shortName>
</recommendedName>
<alternativeName>
<fullName>MUC1-CT</fullName>
</alternativeName>
</component>
</protein>
<gene>
<name type="primary">MUC1</name>
<name type="synonym">PUM</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1990" name="J. Biol. Chem." volume="265" first="15294" last="15299">
<title>Cloning and sequencing of a human pancreatic tumor mucin cDNA.</title>
<authorList>
<person name="Lan M.S."/>
<person name="Batra S.K."/>
<person name="Qi W.-N."/>
<person name="Metzgar R.S."/>
<person name="Hollingsworth M.A."/>
</authorList>
<dbReference type="PubMed" id="2394722"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Pancreatic carcinoma</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1990" name="J. Biol. Chem." volume="265" first="5573" last="5578">
<title>Episialin, a carcinoma-associated mucin, is generated by a polymorphic gene encoding splice variants with alternative amino termini.</title>
<authorList>
<person name="Ligtenberg M.J.L."/>
<person name="Vos H.L."/>
<person name="Gennissen A.M.C."/>
<person name="Hilkens J."/>
</authorList>
<dbReference type="PubMed" id="2318825"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2)</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1990" name="J. Biol. Chem." volume="265" first="15286" last="15293">
<title>Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin.</title>
<authorList>
<person name="Gendler S.J."/>
<person name="Lancaster C.A."/>
<person name="Taylor-Papadimitriou J."/>
<person name="Duhig T."/>
<person name="Peat N."/>
<person name="Burchell J."/>
<person name="Pemberton L."/>
<person name="Lalani E.-N."/>
<person name="Wilson D."/>
</authorList>
<dbReference type="PubMed" id="1697589"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Mammary carcinoma</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="1990" name="Biochem. Biophys. Res. Commun." volume="173" first="1019" last="1029">
<title>Structure and expression of the human polymorphic epithelial mucin gene: an expressed VNTR unit.</title>
<authorList>
<person name="Lancaster C.A."/>
<person name="Peat N."/>
<person name="Duhig T."/>
<person name="Wilson D."/>
<person name="Taylor-Papadimitriou J."/>
<person name="Gendler S.J."/>
</authorList>
<dbReference type="PubMed" id="2268309"/>
<dbReference type="DOI" id="10.1016/s0006-291x(05)80888-5"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1)</scope>
</reference>
<reference key="5">
<citation type="journal article" date="1990" name="Eur. J. Biochem." volume="189" first="463" last="473">
<title>Human epithelial tumor antigen cDNA sequences. Differential splicing may generate multiple protein forms.</title>
<authorList>
<person name="Wreschner D.H."/>
<person name="Hareuveni M."/>
<person name="Tsarfaty I."/>
<person name="Smorodinsky N."/>
<person name="Horev J."/>
<person name="Zaretsky J."/>
<person name="Kotkes P."/>
<person name="Weiss M."/>
<person name="Lathe R."/>
<person name="Dion A."/>
<person name="Keydar I."/>
</authorList>
<dbReference type="PubMed" id="2351132"/>
<dbReference type="DOI" id="10.1111/j.1432-1033.1990.tb15511.x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5)</scope>
<source>
<tissue>Mammary carcinoma</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="1990" name="Eur. J. Biochem." volume="189" first="475" last="486">
<title>A transcribed gene, containing a variable number of tandem repeats, codes for a human epithelial tumor antigen. cDNA cloning, expression of the transfected gene and over-expression in breast cancer tissue.</title>
<authorList>
<person name="Hareuveni M."/>
<person name="Tsarfaty I."/>
<person name="Zaretsky J."/>
<person name="Kotkes P."/>
<person name="Horev J."/>
<person name="Zrihan S."/>
<person name="Weiss M."/>
<person name="Green S."/>
<person name="Lathe R."/>
<person name="Keydar I."/>
<person name="Wreschner D.H."/>
</authorList>
<dbReference type="PubMed" id="2112460"/>
<dbReference type="DOI" id="10.1111/j.1432-1033.1990.tb15512.x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>Mammary carcinoma</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="1990" name="Gene" volume="93" first="313" last="318">
<title>Isolation and characterization of an expressed hypervariable gene coding for a breast-cancer-associated antigen.</title>
<authorList>
<person name="Tsarfaty I."/>
<person name="Hareuveni M."/>
<person name="Horev J."/>
<person name="Zaretsky J."/>
<person name="Weiss M."/>
<person name="Jeltsch J.-M."/>
<person name="Garnier J.-M."/>
<person name="Lathe R."/>
<person name="Keydar I."/>
<person name="Wreschner D.H."/>
</authorList>
<dbReference type="PubMed" id="1688329"/>
<dbReference type="DOI" id="10.1016/0378-1119(90)90242-j"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1)</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1994" name="Eur. J. Biochem." volume="224" first="787" last="795">
<title>Characterization and molecular cloning of a novel MUC1 protein, devoid of tandem repeats, expressed in human breast cancer tissue.</title>
<authorList>
<person name="Zrihan-Licht S."/>
<person name="Vos H.L."/>
<person name="Baruch A."/>
<person name="Elroy-Stein O."/>
<person name="Sagiv D."/>
<person name="Keydar I."/>
<person name="Hilkens J."/>
<person name="Wreschner D.H."/>
</authorList>
<dbReference type="PubMed" id="7925397"/>
<dbReference type="DOI" id="10.1111/j.1432-1033.1994.00787.x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM Y)</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1997" name="Int. J. Cancer" volume="72" first="87" last="94">
<title>Comparison of MUC-1 mucin expression in epithelial and non-epithelial cancer cell lines and demonstration of a new short variant form (MUC-1/Z).</title>
<authorList>
<person name="Oosterkamp H.M."/>
<person name="Scheiner L."/>
<person name="Stefanova M.C."/>
<person name="Lloyd K.O."/>
<person name="Finstad C.L."/>
</authorList>
<dbReference type="PubMed" id="9212228"/>
<dbReference type="DOI" id="10.1002/(sici)1097-0215(19970703)72:1&lt;87::aid-ijc13&gt;3.0.co;2-7"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 6; Y AND 8)</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="10655" last="10663">
<title>A novel protein derived from the MUC1 gene by alternative splicing and frameshifting.</title>
<authorList>
<person name="Levitin F."/>
<person name="Baruch A."/>
<person name="Weiss M."/>
<person name="Stiegman K."/>
<person name="Hartmann M.L."/>
<person name="Yoeli-Lerner M."/>
<person name="Ziv R."/>
<person name="Zrihan-Licht S."/>
<person name="Shina S."/>
<person name="Gat A."/>
<person name="Lifschitz B."/>
<person name="Simha M."/>
<person name="Stadler Y."/>
<person name="Cholostoy A."/>
<person name="Gil B."/>
<person name="Greaves D."/>
<person name="Keydar I."/>
<person name="Zaretsky J."/>
<person name="Smorodinsky N."/>
<person name="Wreschner D.H."/>
</authorList>
<dbReference type="PubMed" id="15623537"/>
<dbReference type="DOI" id="10.1074/jbc.m406943200"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM ZD)</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2013" name="Cancer Immunol. Immunother." volume="62" first="423" last="435">
<title>Human mucin MUC1 RNA undergoes different types of alternative splicing resulting in multiple isoforms.</title>
<authorList>
<person name="Zhang L."/>
<person name="Vlad A."/>
<person name="Milcarek C."/>
<person name="Finn O.J."/>
</authorList>
<dbReference type="PubMed" id="22941036"/>
<dbReference type="DOI" id="10.1007/s00262-012-1325-2"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 6; E2; J13; M6; S2; T10; Y-LSP AND ZD)</scope>
<scope>ALTERNATIVE SPLICING</scope>
<scope>VARIANT MET-1117</scope>
</reference>
<reference key="12">
<citation type="submission" date="2001-02" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of a new potential secreted short variant form of MUC1 mucin in epithelial cancer cell line.</title>
<authorList>
<person name="Zhang L.X."/>
<person name="Li C.H."/>
<person name="Sun L.Y."/>
<person name="Yue W."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 9)</scope>
<source>
<tissue>Carcinoma</tissue>
</source>
</reference>
<reference key="13">
<citation type="journal article" date="2003" name="Sheng Wu Gong Cheng Xue Bao" volume="19" first="337" last="342">
<title>Soluble expression of peptide containing MUC1/Y-specific epitope in Escherichia coli and preparation of the antibody.</title>
<authorList>
<person name="Zhang L.X."/>
<person name="Li C.H."/>
<person name="Sun L.Y."/>
<person name="Wang M."/>
<person name="Lu H.J."/>
</authorList>
<dbReference type="PubMed" id="15969018"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM Y)</scope>
<scope>VARIANT MET-1117</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="14">
<citation type="submission" date="2003-06" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of a new MUC1 short variant mRNA F from HeLa cells.</title>
<authorList>
<person name="Zhang L.X."/>
<person name="Lu H.J."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM F)</scope>
</reference>
<reference key="15">
<citation type="submission" date="2003-06" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of a new MUC1 short variant mRNA S2 from HeLa cells.</title>
<authorList>
<person name="Zhang L.X."/>
<person name="Lu H.J."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM S2)</scope>
</reference>
<reference key="16">
<citation type="submission" date="2007-06" db="EMBL/GenBank/DDBJ databases">
<title>Isolation of MUC1 isoforms from MCF7 cells.</title>
<authorList>
<person name="Zhang L."/>
<person name="Finn O.J."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM M6)</scope>
</reference>
<reference key="17">
<citation type="submission" date="2003-11" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS MET-1117 AND ASN-1142</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2006" name="Nature" volume="441" first="315" last="321">
<title>The DNA sequence and biological annotation of human chromosome 1.</title>
<authorList>
<person name="Gregory S.G."/>
<person name="Barlow K.F."/>
<person name="McLay K.E."/>
<person name="Kaul R."/>
<person name="Swarbreck D."/>
<person name="Dunham A."/>
<person name="Scott C.E."/>
<person name="Howe K.L."/>
<person name="Woodfine K."/>
<person name="Spencer C.C.A."/>
<person name="Jones M.C."/>
<person name="Gillson C."/>
<person name="Searle S."/>
<person name="Zhou Y."/>
<person name="Kokocinski F."/>
<person name="McDonald L."/>
<person name="Evans R."/>
<person name="Phillips K."/>
<person name="Atkinson A."/>
<person name="Cooper R."/>
<person name="Jones C."/>
<person name="Hall R.E."/>
<person name="Andrews T.D."/>
<person name="Lloyd C."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Anderson F."/>
<person name="Andrew R.W."/>
<person name="Ashwell R.I.S."/>
<person name="Aubin K."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Beasley H."/>
<person name="Bethel G."/>
<person name="Bird C.P."/>
<person name="Bray-Allen S."/>
<person name="Brown J.Y."/>
<person name="Brown A.J."/>
<person name="Buckley D."/>
<person name="Burton J."/>
<person name="Bye J."/>
<person name="Carder C."/>
<person name="Chapman J.C."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C."/>
<person name="Cobley V."/>
<person name="Collier R.E."/>
<person name="Corby N."/>
<person name="Coville G.J."/>
<person name="Davies J."/>
<person name="Deadman R."/>
<person name="Dunn M."/>
<person name="Earthrowl M."/>
<person name="Ellington A.G."/>
<person name="Errington H."/>
<person name="Frankish A."/>
<person name="Frankland J."/>
<person name="French L."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Gay L."/>
<person name="Ghori M.R.J."/>
<person name="Gibson R."/>
<person name="Gilby L.M."/>
<person name="Gillett W."/>
<person name="Glithero R.J."/>
<person name="Grafham D.V."/>
<person name="Griffiths C."/>
<person name="Griffiths-Jones S."/>
<person name="Grocock R."/>
<person name="Hammond S."/>
<person name="Harrison E.S.I."/>
<person name="Hart E."/>
<person name="Haugen E."/>
<person name="Heath P.D."/>
<person name="Holmes S."/>
<person name="Holt K."/>
<person name="Howden P.J."/>
<person name="Hunt A.R."/>
<person name="Hunt S.E."/>
<person name="Hunter G."/>
<person name="Isherwood J."/>
<person name="James R."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Joy A."/>
<person name="Kay M."/>
<person name="Kershaw J.K."/>
<person name="Kibukawa M."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A.J."/>
<person name="Lad H."/>
<person name="Laird G."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Lloyd D.M."/>
<person name="Loveland J."/>
<person name="Lovell J."/>
<person name="Lush M.J."/>
<person name="Lyne R."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="Matthews N.S.W."/>
<person name="McLaren S."/>
<person name="Milne S."/>
<person name="Mistry S."/>
<person name="Moore M.J.F."/>
<person name="Nickerson T."/>
<person name="O'Dell C.N."/>
<person name="Oliver K."/>
<person name="Palmeiri A."/>
<person name="Palmer S.A."/>
<person name="Parker A."/>
<person name="Patel D."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Pelan S."/>
<person name="Phelps K."/>
<person name="Phillimore B.J."/>
<person name="Plumb R."/>
<person name="Rajan J."/>
<person name="Raymond C."/>
<person name="Rouse G."/>
<person name="Saenphimmachak C."/>
<person name="Sehra H.K."/>
<person name="Sheridan E."/>
<person name="Shownkeen R."/>
<person name="Sims S."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Steward C."/>
<person name="Subramanian S."/>
<person name="Sycamore N."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Van Helmond Z."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="White S."/>
<person name="Whitehead S.L."/>
<person name="Wilkinson J.E."/>
<person name="Willey D.L."/>
<person name="Williams H."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Wu Z."/>
<person name="Coulson A."/>
<person name="Vaudin M."/>
<person name="Sulston J.E."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Wooster R."/>
<person name="Dunham I."/>
<person name="Carter N.P."/>
<person name="McVean G."/>
<person name="Ross M.T."/>
<person name="Harrow J."/>
<person name="Olson M.V."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Bentley D.R."/>
</authorList>
<dbReference type="PubMed" id="16710414"/>
<dbReference type="DOI" id="10.1038/nature04727"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="19">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS Y AND Y-LSP)</scope>
</reference>
<reference key="21">
<citation type="journal article" date="1988" name="J. Biol. Chem." volume="263" first="12820" last="12823">
<title>A highly immunogenic region of a human polymorphic epithelial mucin expressed by carcinomas is made up of tandem repeats.</title>
<authorList>
<person name="Gendler S.J."/>
<person name="Taylor-Papadimitriou J."/>
<person name="Duhig T."/>
<person name="Rothbard J."/>
<person name="Burchell J."/>
</authorList>
<dbReference type="PubMed" id="3417635"/>
</citation>
<scope>PARTIAL NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="22">
<citation type="journal article" date="1989" name="Biochem. Biophys. Res. Commun." volume="165" first="644" last="649">
<title>Sequence analysis of the 5' region of the human DF3 breast carcinoma-associated antigen gene.</title>
<authorList>
<person name="Abe M."/>
<person name="Siddiqui J."/>
<person name="Kufe D."/>
</authorList>
<dbReference type="PubMed" id="2597151"/>
<dbReference type="DOI" id="10.1016/s0006-291x(89)80014-2"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1-160 (ISOFORM 2)</scope>
</reference>
<reference key="23">
<citation type="journal article" date="1996" name="Int. J. Cancer" volume="66" first="55" last="59">
<title>Preoperative diagnosis of thyroid papillary carcinoma by reverse transcriptase polymerase chain reaction of the MUC1 gene.</title>
<authorList>
<person name="Weiss M."/>
<person name="Baruch A."/>
<person name="Keydar I."/>
<person name="Wreschner D.H."/>
</authorList>
<dbReference type="PubMed" id="8608966"/>
<dbReference type="DOI" id="10.1002/(sici)1097-0215(19960328)66:1&lt;55::aid-ijc10&gt;3.0.co;2-a"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1-109 (ISOFORM 2)</scope>
<source>
<tissue>Thyroid</tissue>
</source>
</reference>
<reference key="24">
<citation type="journal article" date="1996" name="Oncology" volume="53" first="118" last="126">
<title>Mucin mRNA expression in lung adenocarcinoma cell lines and tissues.</title>
<authorList>
<person name="Yu C.J."/>
<person name="Yang P.C."/>
<person name="Shew J.Y."/>
<person name="Hong T.M."/>
<person name="Yang S.C."/>
<person name="Lee Y.C."/>
<person name="Lee L.N."/>
<person name="Luh K.T."/>
<person name="Wu C.W."/>
</authorList>
<dbReference type="PubMed" id="8604237"/>
<dbReference type="DOI" id="10.1159/000227547"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1-89</scope>
<source>
<tissue>Lung</tissue>
</source>
</reference>
<reference key="25">
<citation type="submission" date="1992-10" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Buluwela L."/>
<person name="Liu Q."/>
<person name="Luqmani Y.A."/>
<person name="Gomm J.J."/>
<person name="Coombes R.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1-46 (ISOFORMS 3 AND 4)</scope>
<source>
<tissue>Mammary carcinoma</tissue>
</source>
</reference>
<reference key="26">
<citation type="journal article" date="2001" name="Biochem. Biophys. Res. Commun." volume="283" first="715" last="720">
<title>Identification of MUC1 proteolytic cleavage sites in vivo.</title>
<authorList>
<person name="Parry S."/>
<person name="Silverman H.S."/>
<person name="McDermott K."/>
<person name="Willis A."/>
<person name="Hollingsworth M.A."/>
<person name="Harris A."/>
</authorList>
<dbReference type="PubMed" id="11341784"/>
<dbReference type="DOI" id="10.1006/bbrc.2001.4775"/>
</citation>
<scope>PROTEIN SEQUENCE OF 24-33; 28-37 AND 1098-1107</scope>
<scope>PROTEOLYTIC PROCESSING</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="33374" last="33386">
<title>The MUC1 SEA module is a self-cleaving domain.</title>
<authorList>
<person name="Levitin F."/>
<person name="Stern O."/>
<person name="Weiss M."/>
<person name="Gil-Henn C."/>
<person name="Ziv R."/>
<person name="Prokocimer Z."/>
<person name="Smorodinsky N.I."/>
<person name="Rubinstein D.B."/>
<person name="Wreschner D.H."/>
</authorList>
<dbReference type="PubMed" id="15987679"/>
<dbReference type="DOI" id="10.1074/jbc.m506047200"/>
</citation>
<scope>PROTEIN SEQUENCE OF 1098-1111</scope>
<scope>PROTEOLYTIC CLEAVAGE</scope>
<scope>MUTAGENESIS OF SER-1098</scope>
</reference>
<reference key="28">
<citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="18165" last="18172">
<title>High density O-glycosylation on tandem repeat peptide from secretory MUC1 of T47D breast cancer cells.</title>
<authorList>
<person name="Mueller S."/>
<person name="Alving K."/>
<person name="Peter-Katalinic J."/>
<person name="Zachara N."/>
<person name="Gooley A.A."/>
<person name="Hanisch F.-G."/>
</authorList>
<dbReference type="PubMed" id="10373415"/>
<dbReference type="DOI" id="10.1074/jbc.274.26.18165"/>
</citation>
<scope>PROTEIN SEQUENCE OF TANDEM REPEAT</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>GLYCOSYLATION</scope>
</reference>
<reference key="29">
<citation type="journal article" date="1994" name="FEBS Lett." volume="356" first="130" last="136">
<title>Tyrosine phosphorylation of the MUC1 breast cancer membrane proteins. Cytokine receptor-like molecules.</title>
<authorList>
<person name="Zrihan-Licht S."/>
<person name="Baruch A."/>
<person name="Elroy-Stein O."/>
<person name="Keydar I."/>
<person name="Wreschner D.H."/>
</authorList>
<dbReference type="PubMed" id="7988707"/>
<dbReference type="DOI" id="10.1016/0014-5793(94)01251-2"/>
</citation>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="30">
<citation type="journal article" date="1995" name="Cancer Res." volume="55" first="4000" last="4003">
<title>Association of the DF3/MUC1 breast cancer antigen with Grb2 and the Sos/Ras exchange protein.</title>
<authorList>
<person name="Pandey P."/>
<person name="Kharbanda S."/>
<person name="Kufe D."/>
</authorList>
<dbReference type="PubMed" id="7664271"/>
</citation>
<scope>IDENTIFICATION IN A COMPLEX WITH SOS1 AND GRB2</scope>
<scope>INTERACTION WITH GRB2 AND SOS1</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="31">
<citation type="journal article" date="1995" name="Eur. J. Biochem." volume="229" first="140" last="147">
<title>Studies on the order and site specificity of GalNAc transfer to MUC1 tandem repeats by UDP-GalNAc: polypeptide N-acetylgalactosaminyltransferase from milk or mammary carcinoma cells.</title>
<authorList>
<person name="Stadie T.R."/>
<person name="Chai W."/>
<person name="Lawson A.M."/>
<person name="Byfield P.G."/>
<person name="Hanisch F.G."/>
</authorList>
<dbReference type="PubMed" id="7744025"/>
<dbReference type="DOI" id="10.1111/j.1432-1033.1995.0140l.x"/>
</citation>
<scope>GLYCOSYLATION AT THR-131 AND THR-139</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="32">
<citation type="journal article" date="1997" name="J. Biol. Chem." volume="272" first="12492" last="12494">
<title>Interaction of the DF3/MUC1 breast carcinoma-associated antigen and beta-catenin in cell adhesion.</title>
<authorList>
<person name="Yamamoto M."/>
<person name="Bharti A."/>
<person name="Li Y."/>
<person name="Kufe D."/>
</authorList>
<dbReference type="PubMed" id="9139698"/>
<dbReference type="DOI" id="10.1074/jbc.272.19.12492"/>
</citation>
<scope>INTERACTION WITH CTNNB1 AND JUP</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="33">
<citation type="journal article" date="1997" name="J. Biol. Chem." volume="272" first="24780" last="24793">
<title>Localization of O-glycosylation sites on glycopeptide fragments from lactation-associated MUC1. All putative sites within the tandem repeat are glycosylation targets in vivo.</title>
<authorList>
<person name="Mueller S."/>
<person name="Goletz S."/>
<person name="Packer N.H."/>
<person name="Gooley A.A."/>
<person name="Lawson A.M."/>
<person name="Hanisch F.-G."/>
</authorList>
<dbReference type="PubMed" id="9312074"/>
<dbReference type="DOI" id="10.1074/jbc.272.40.24780"/>
</citation>
<scope>GLYCOSYLATION</scope>
</reference>
<reference key="34">
<citation type="journal article" date="1998" name="Gut" volume="42" first="220" last="226">
<title>Developmental expression of mucin genes in the human gastrointestinal system.</title>
<authorList>
<person name="Reid C.J."/>
<person name="Harris A."/>
</authorList>
<dbReference type="PubMed" id="9536947"/>
<dbReference type="DOI" id="10.1136/gut.42.2.220"/>
</citation>
<scope>DEVELOPMENTAL STAGE</scope>
</reference>
<reference key="35">
<citation type="journal article" date="1998" name="J. Mass Spectrom." volume="33" first="358" last="362">
<title>Localization of O-glycosylation sites of MUC1 tandem repeats by QTOF ESI mass spectrometry.</title>
<authorList>
<person name="Hanisch F.G."/>
<person name="Green B.N."/>
<person name="Bateman R."/>
<person name="Peter-Katalinic J."/>
</authorList>
<dbReference type="PubMed" id="9597769"/>
<dbReference type="DOI" id="10.1002/(sici)1096-9888(199804)33:4&lt;358::aid-jms642&gt;3.0.co;2-3"/>
</citation>
<scope>GLYCOSYLATION AT THR-131 AND THR-139</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="36">
<citation type="journal article" date="1998" name="Mol. Cell. Biol." volume="18" first="7216" last="7224">
<title>Interaction of glycogen synthase kinase 3beta with the DF3/MUC1 carcinoma-associated antigen and beta-catenin.</title>
<authorList>
<person name="Li Y."/>
<person name="Bharti A."/>
<person name="Chen D."/>
<person name="Gong J."/>
<person name="Kufe D."/>
</authorList>
<dbReference type="PubMed" id="9819408"/>
<dbReference type="DOI" id="10.1128/mcb.18.12.7216"/>
</citation>
<scope>INTERACTION WITH GSK3B AND CTNNB1</scope>
<scope>PHOSPHORYLATION AT SER-1227</scope>
<scope>MUTAGENESIS OF SER-1223 AND SER-1227</scope>
</reference>
<reference key="37">
<citation type="journal article" date="1999" name="Cancer Res." volume="59" first="1552" last="1561">
<title>The breast cancer-associated MUC1 gene generates both a receptor and its cognate binding protein.</title>
<authorList>
<person name="Baruch A."/>
<person name="Hartmann M.-L."/>
<person name="Yoeli M."/>
<person name="Adereth Y."/>
<person name="Greenstein S."/>
<person name="Stadler Y."/>
<person name="Skornik Y."/>
<person name="Zaretsky J."/>
<person name="Smorodinsky N.I."/>
<person name="Keydar I."/>
<person name="Wreschner D.H."/>
</authorList>
<dbReference type="PubMed" id="10197628"/>
</citation>
<scope>CHARACTERIZATION (ISOFORM Y)</scope>
<scope>MUTAGENESIS OF ASP-1116</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2001" name="Digestion 63 Suppl." volume="1" first="87" last="92">
<title>MUC1 mucin core protein binds to the domain 1 of ICAM-1.</title>
<authorList>
<person name="Hayashi T."/>
<person name="Takahashi T."/>
<person name="Motoya S."/>
<person name="Ishida T."/>
<person name="Itoh F."/>
<person name="Adachi M."/>
<person name="Hinoda Y."/>
<person name="Imai K."/>
</authorList>
<dbReference type="PubMed" id="11173916"/>
<dbReference type="DOI" id="10.1159/000051917"/>
</citation>
<scope>INTERACTION WITH ICAM1</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2001" name="J. Histochem. Cytochem." volume="49" first="67" last="77">
<title>Mucin MUC1 is seen in cell surface protrusions together with ezrin in immunoelectron tomography and is concentrated at tips of filopodial protrusions in MCF-7 breast carcinoma cells.</title>
<authorList>
<person name="Bennett R. Jr."/>
<person name="Jaervelae T."/>
<person name="Engelhardt P."/>
<person name="Kostamovaara L."/>
<person name="Sparks P."/>
<person name="Carpen O."/>
<person name="Turunen O."/>
<person name="Vaheri A."/>
</authorList>
<dbReference type="PubMed" id="11118479"/>
<dbReference type="DOI" id="10.1177/002215540104900107"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="6061" last="6064">
<title>The c-Src tyrosine kinase regulates signaling of the human DF3/MUC1 carcinoma-associated antigen with GSK3 beta and beta-catenin.</title>
<authorList>
<person name="Li Y."/>
<person name="Kuwahara H."/>
<person name="Ren J."/>
<person name="Wen G."/>
<person name="Kufe D."/>
</authorList>
<dbReference type="PubMed" id="11152665"/>
<dbReference type="DOI" id="10.1074/jbc.c000754200"/>
</citation>
<scope>INTERACTION WITH SRC; GSK3B AND CTNNB1</scope>
<scope>PHOSPHORYLATION AT TYR-1229</scope>
<scope>MUTAGENESIS OF TYR-1229</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="27764" last="27769">
<title>Identification and topology of variant sequences within individual repeat domains of the human epithelial tumor mucin MUC1.</title>
<authorList>
<person name="Engelmann K."/>
<person name="Baldus S.E."/>
<person name="Hanisch F.-G."/>
</authorList>
<dbReference type="PubMed" id="11350974"/>
<dbReference type="DOI" id="10.1074/jbc.m103187200"/>
</citation>
<scope>POLYMORPHISM WITHIN THE REPEAT</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="35239" last="35242">
<title>The epidermal growth factor receptor regulates interaction of the human DF3/MUC1 carcinoma antigen with c-Src and beta-catenin.</title>
<authorList>
<person name="Li Y."/>
<person name="Ren J."/>
<person name="Yu W."/>
<person name="Li Q."/>
<person name="Kuwahara H."/>
<person name="Yin L."/>
<person name="Carraway K.L. III"/>
<person name="Kufe D."/>
</authorList>
<dbReference type="PubMed" id="11483589"/>
<dbReference type="DOI" id="10.1074/jbc.c100359200"/>
</citation>
<scope>INTERACTION WITH EGFR</scope>
<scope>PHOSPHORYLATION AT TYR-1229 BY EGFR</scope>
<scope>MUTAGENESIS OF TYR-1191; TYR-1203; TYR-1209; TYR-1218 AND TYR-1229</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="17616" last="17622">
<title>Protein kinase C delta regulates function of the DF3/MUC1 carcinoma antigen in beta-catenin signaling.</title>
<authorList>
<person name="Ren J."/>
<person name="Li Y."/>
<person name="Kufe D."/>
</authorList>
<dbReference type="PubMed" id="11877440"/>
<dbReference type="DOI" id="10.1074/jbc.m200436200"/>
</citation>
<scope>PHOSPHORYLATION AT THR-1224</scope>
<scope>INTERACTION WITH PRKCD</scope>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF SER-1223; THR-1224 AND SER-1227</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2003" name="Biochem. Biophys. Res. Commun." volume="310" first="341" last="346">
<title>Identification of four sites of stimulated tyrosine phosphorylation in the MUC1 cytoplasmic tail.</title>
<authorList>
<person name="Wang H."/>
<person name="Lillehoj E.P."/>
<person name="Kim K.C."/>
</authorList>
<dbReference type="PubMed" id="14521915"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2003.09.030"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-1203; TYR-1212; TYR-1229 AND TYR-1243</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2003" name="Cancer Biol. Ther." volume="2" first="187" last="193">
<title>DF3/MUC1 signaling in multiple myeloma cells is regulated by interleukin-7.</title>
<authorList>
<person name="Li Y."/>
<person name="Chen W."/>
<person name="Ren J."/>
<person name="Yu W.H."/>
<person name="Li Q."/>
<person name="Yoshida K."/>
<person name="Kufe D."/>
</authorList>
<dbReference type="PubMed" id="12750561"/>
<dbReference type="DOI" id="10.4161/cbt.2.2.282"/>
</citation>
<scope>INTERACTION WITH LYN</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2003" name="Cancer Biol. Ther." volume="2" first="702" last="706">
<title>MUC1 cytoplasmic domain coactivates Wnt target gene transcription and confers transformation.</title>
<authorList>
<person name="Huang L."/>
<person name="Ren J."/>
<person name="Chen D."/>
<person name="Li Y."/>
<person name="Kharbanda S."/>
<person name="Kufe D."/>
</authorList>
<dbReference type="PubMed" id="14688481"/>
</citation>
<scope>INTERACTION WITH CTNNB1</scope>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF TYR-1229</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="3386" last="3394">
<title>Tumor necrosis factor-alpha converting enzyme/ADAM 17 mediates MUC1 shedding.</title>
<authorList>
<person name="Thathiah A."/>
<person name="Blobel C.P."/>
<person name="Carson D.D."/>
</authorList>
<dbReference type="PubMed" id="12441351"/>
<dbReference type="DOI" id="10.1074/jbc.m208326200"/>
</citation>
<scope>INTERACTION WITH ADAM17</scope>
<scope>CLEAVAGE</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="38029" last="38039">
<title>Nuclear association of the cytoplasmic tail of MUC1 and beta-catenin.</title>
<authorList>
<person name="Wen Y."/>
<person name="Caffrey T.C."/>
<person name="Wheelock M.J."/>
<person name="Johnson K.R."/>
<person name="Hollingsworth M.A."/>
</authorList>
<dbReference type="PubMed" id="12832415"/>
<dbReference type="DOI" id="10.1074/jbc.m304333200"/>
</citation>
<scope>INTERACTION WITH CTNNB1</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2003" name="Mol. Cancer Res." volume="1" first="765" last="775">
<title>Heregulin targets gamma-catenin to the nucleolus by a mechanism dependent on the DF3/MUC1 oncoprotein.</title>
<authorList>
<person name="Li Y."/>
<person name="Yu W.-H."/>
<person name="Ren J."/>
<person name="Chen W."/>
<person name="Huang L."/>
<person name="Kharbanda S."/>
<person name="Loda M."/>
<person name="Kufe D."/>
</authorList>
<dbReference type="PubMed" id="12939402"/>
</citation>
<scope>INTERACTION WITH ERBB2; ERBB3 AND ERBB4</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF 1187-ARG--LYS-1189</scope>
</reference>
<reference key="50">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="53071" last="53077">
<title>MUC1 membrane trafficking is modulated by multiple interactions.</title>
<authorList>
<person name="Kinlough C.L."/>
<person name="Poland P.A."/>
<person name="Bruns J.B."/>
<person name="Harkleroad K.L."/>
<person name="Hughey R.P."/>
</authorList>
<dbReference type="PubMed" id="15471854"/>
<dbReference type="DOI" id="10.1074/jbc.m409360200"/>
</citation>
<scope>INTERACTION WITH AP1S2 AND GRB2</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF TYR-1191; TYR-1203; TYR-1229 AND TYR-1243</scope>
</reference>
<reference key="51">
<citation type="journal article" date="2005" name="Cancer Cell" volume="7" first="167" last="178">
<title>Human MUC1 oncoprotein regulates p53-responsive gene transcription in the genotoxic stress response.</title>
<authorList>
<person name="Wei X."/>
<person name="Xu H."/>
<person name="Kufe D."/>
</authorList>
<dbReference type="PubMed" id="15710329"/>
<dbReference type="DOI" id="10.1016/j.ccr.2005.01.008"/>
</citation>
<scope>INTERACTION WITH TP53</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="52">
<citation type="journal article" date="2005" name="Cancer Res." volume="65" first="10413" last="10422">
<title>MUC1 oncoprotein blocks glycogen synthase kinase 3beta-mediated phosphorylation and degradation of beta-catenin.</title>
<authorList>
<person name="Huang L."/>
<person name="Chen D."/>
<person name="Liu D."/>
<person name="Yin L."/>
<person name="Kharbanda S."/>
<person name="Kufe D."/>
</authorList>
<dbReference type="PubMed" id="16288032"/>
<dbReference type="DOI" id="10.1158/0008-5472.can-05-2474"/>
</citation>
<scope>INTERACTION WITH GSK3B</scope>
<scope>PHOSPHORYLATION</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="53">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="28827" last="28827">
<authorList>
<person name="Kinlough C.L."/>
<person name="Poland P.A."/>
<person name="Bruns J.B."/>
<person name="Harkleroad K.L."/>
<person name="Hughey R.P."/>
</authorList>
</citation>
<scope>ERRATUM OF PUBMED:16288032</scope>
</reference>
<reference key="54">
<citation type="journal article" date="2005" name="Glycobiology" volume="15" first="1111" last="1124">
<title>Transmembrane and secreted MUC1 probes show trafficking-dependent changes in O-glycan core profiles.</title>
<authorList>
<person name="Engelmann K."/>
<person name="Kinlough C.L."/>
<person name="Muller S."/>
<person name="Razawi H."/>
<person name="Baldus S.E."/>
<person name="Hughey R.P."/>
<person name="Hanisch F.-G."/>
</authorList>
<dbReference type="PubMed" id="15972891"/>
<dbReference type="DOI" id="10.1093/glycob/cwi099"/>
</citation>
<scope>STRUCTURE OF CARBOHYDRATES</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="55">
<citation type="journal article" date="2005" name="J. Leukoc. Biol." volume="77" first="90" last="99">
<title>MUC1 (CD227) interacts with lck tyrosine kinase in Jurkat lymphoma cells and normal T cells.</title>
<authorList>
<person name="Mukherjee P."/>
<person name="Tinder T.L."/>
<person name="Basu G.D."/>
<person name="Gendler S.J."/>
</authorList>
<dbReference type="PubMed" id="15513966"/>
<dbReference type="DOI" id="10.1189/jlb.0604333"/>
</citation>
<scope>INTERACTION WITH LCK</scope>
<scope>PHOSPHORYLATION</scope>
<scope>FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="56">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="12112" last="12122">
<title>Recycling of MUC1 is dependent on its palmitoylation.</title>
<authorList>
<person name="Kinlough C.L."/>
<person name="McMahan R.J."/>
<person name="Poland P.A."/>
<person name="Bruns J.B."/>
<person name="Harkleroad K.L."/>
<person name="Stremple R.J."/>
<person name="Kashlan O.B."/>
<person name="Weixel K.M."/>
<person name="Weisz O.A."/>
<person name="Hughey R.P."/>
</authorList>
<dbReference type="PubMed" id="16507569"/>
<dbReference type="DOI" id="10.1074/jbc.m512996200"/>
</citation>
<scope>PALMITOYLATION AT CYS-1184 AND CYS-1186</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH AP1S1 AND AP1S2</scope>
<scope>MUTAGENESIS OF CYS-1184; CYS-1186; TYR-1203 AND 1187-ARG--LYS-1189</scope>
</reference>
<reference key="57">
<citation type="journal article" date="2006" name="Mol. Cell" volume="21" first="295" last="305">
<title>MUC1 oncoprotein stabilizes and activates estrogen receptor alpha.</title>
<authorList>
<person name="Wei X."/>
<person name="Xu H."/>
<person name="Kufe D."/>
</authorList>
<dbReference type="PubMed" id="16427018"/>
<dbReference type="DOI" id="10.1016/j.molcel.2005.11.030"/>
</citation>
<scope>INTERACTION WITH ESR1</scope>
</reference>
<reference key="58">
<citation type="journal article" date="2007" name="Biochim. Biophys. Acta" volume="1773" first="1028" last="1038">
<title>MUC1 inhibits cell proliferation by a beta-catenin-dependent mechanism.</title>
<authorList>
<person name="Lillehoj E.P."/>
<person name="Lu W."/>
<person name="Kiser T."/>
<person name="Goldblum S.E."/>
<person name="Kim K.C."/>
</authorList>
<dbReference type="PubMed" id="17524503"/>
<dbReference type="DOI" id="10.1016/j.bbamcr.2007.04.009"/>
</citation>
<scope>INTERACTION WITH CTNNB1</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="59">
<citation type="journal article" date="2007" name="Cancer Res." volume="67" first="1853" last="1858">
<title>Human mucin 1 oncoprotein represses transcription of the p53 tumor suppressor gene.</title>
<authorList>
<person name="Wei X."/>
<person name="Xu H."/>
<person name="Kufe D."/>
</authorList>
<dbReference type="PubMed" id="17308127"/>
<dbReference type="DOI" id="10.1158/0008-5472.can-06-3063"/>
</citation>
<scope>INTERACTION WITH KLF4</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="60">
<citation type="journal article" date="2007" name="Cancer Res." volume="67" first="5201" last="5210">
<title>Platelet-derived growth factor receptor beta-mediated phosphorylation of MUC1 enhances invasiveness in pancreatic adenocarcinoma cells.</title>
<authorList>
<person name="Singh P.K."/>
<person name="Wen Y."/>
<person name="Swanson B.J."/>
<person name="Shanmugam K."/>
<person name="Kazlauskas A."/>
<person name="Cerny R.L."/>
<person name="Gendler S.J."/>
<person name="Hollingsworth M.A."/>
</authorList>
<dbReference type="PubMed" id="17545600"/>
<dbReference type="DOI" id="10.1158/0008-5472.can-06-4647"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-1203; TYR-1218 AND TYR-1229</scope>
<scope>MUTAGENESIS OF TYR-1203 AND TYR-1218</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="61">
<citation type="journal article" date="2007" name="Oncogene" volume="26" first="1693" last="1701">
<title>MUC1 is a novel regulator of ErbB1 receptor trafficking.</title>
<authorList>
<person name="Pochampalli M.R."/>
<person name="el Bejjani R.M."/>
<person name="Schroeder J.A."/>
</authorList>
<dbReference type="PubMed" id="16983337"/>
<dbReference type="DOI" id="10.1038/sj.onc.1209976"/>
</citation>
<scope>INTERACTION WITH EGFR</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="62">
<citation type="journal article" date="2010" name="Clin. Chim. Acta" volume="411" first="1869" last="1874">
<title>CA 15-3: uses and limitation as a biomarker for breast cancer.</title>
<authorList>
<person name="Duffy M.J."/>
<person name="Evoy D."/>
<person name="McDermott E.W."/>
</authorList>
<dbReference type="PubMed" id="20816948"/>
<dbReference type="DOI" id="10.1016/j.cca.2010.08.039"/>
</citation>
<scope>MARKER IN BREAST CANCER</scope>
</reference>
<reference key="63">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1227</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="64">
<citation type="journal article" date="2013" name="Nat. Genet." volume="45" first="299" last="303">
<title>Mutations causing medullary cystic kidney disease type 1 lie in a large VNTR in MUC1 missed by massively parallel sequencing.</title>
<authorList>
<person name="Kirby A."/>
<person name="Gnirke A."/>
<person name="Jaffe D.B."/>
<person name="Baresova V."/>
<person name="Pochet N."/>
<person name="Blumenstiel B."/>
<person name="Ye C."/>
<person name="Aird D."/>
<person name="Stevens C."/>
<person name="Robinson J.T."/>
<person name="Cabili M.N."/>
<person name="Gat-Viks I."/>
<person name="Kelliher E."/>
<person name="Daza R."/>
<person name="DeFelice M."/>
<person name="Hulkova H."/>
<person name="Sovova J."/>
<person name="Vylet'al P."/>
<person name="Antignac C."/>
<person name="Guttman M."/>
<person name="Handsaker R.E."/>
<person name="Perrin D."/>
<person name="Steelman S."/>
<person name="Sigurdsson S."/>
<person name="Scheinman S.J."/>
<person name="Sougnez C."/>
<person name="Cibulskis K."/>
<person name="Parkin M."/>
<person name="Green T."/>
<person name="Rossin E."/>
<person name="Zody M.C."/>
<person name="Xavier R.J."/>
<person name="Pollak M.R."/>
<person name="Alper S.L."/>
<person name="Lindblad-Toh K."/>
<person name="Gabriel S."/>
<person name="Hart P.S."/>
<person name="Regev A."/>
<person name="Nusbaum C."/>
<person name="Kmoch S."/>
<person name="Bleyer A.J."/>
<person name="Lander E.S."/>
<person name="Daly M.J."/>
</authorList>
<dbReference type="PubMed" id="23396133"/>
<dbReference type="DOI" id="10.1038/ng.2543"/>
</citation>
<scope>INVOLVEMENT IN MCKD1</scope>
</reference>
<reference key="65">
<citation type="journal article" date="2006" name="Glycobiology" volume="16" first="623" last="634">
<title>N-glycosylation of the MUC1 mucin in epithelial cells and secretions.</title>
<authorList>
<person name="Parry S."/>
<person name="Hanisch F.G."/>
<person name="Leir S.H."/>
<person name="Sutton-Smith M."/>
<person name="Morris H.R."/>
<person name="Dell A."/>
<person name="Harris A."/>
</authorList>
<dbReference type="PubMed" id="16585136"/>
<dbReference type="DOI" id="10.1093/glycob/cwj110"/>
</citation>
<scope>STRUCTURE BY NMR OF 1041-1097 AND 1098-1152 OF WILD TYPE AND MUTANT ALA-1098</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>STRUCTURE OF CARBOHYDRATES</scope>
<scope>AUTOCATALYTIC CLEAVAGE</scope>
</reference>
<comment type="function">
<text>The alpha subunit has cell adhesive properties. Can act both as an adhesion and an anti-adhesion protein. May provide a protective layer on epithelial cells against bacterial and enzyme attack.</text>
</comment>
<comment type="function">
<text>The beta subunit contains a C-terminal domain which is involved in cell signaling, through phosphorylations and protein-protein interactions. Modulates signaling in ERK, SRC and NF-kappa-B pathways. In activated T-cells, influences directly or indirectly the Ras/MAPK pathway. Promotes tumor progression. Regulates TP53-mediated transcription and determines cell fate in the genotoxic stress response. Binds, together with KLF4, the PE21 promoter element of TP53 and represses TP53 activity.</text>
</comment>
<comment type="subunit">
<text evidence="8 9 12 13 14 15 16 17 19 20 21 22 26 27 28 29 30 31 36 39 44">The alpha subunit forms a tight, non-covalent heterodimeric complex with the proteolytically-released beta-subunit. Interaction, via the tandem repeat region, with domain 1 of ICAM1 is implicated in cell migration and metastases. Isoform 1 binds directly the SH2 domain of GRB2, and forms a MUC1/GRB2/SOS1 complex involved in RAS signaling. The cytoplasmic tail (MUC1CT) interacts with several proteins such as SRC, CTNNB1 and ERBs. Interaction with the SH2 domain of CSK decreases interaction with GSK3B. Interacts with CTNNB1/beta-catenin and JUP/gamma-catenin and promotes cell adhesion. Interaction with JUP/gamma-catenin is induced by heregulin. Binds PRKCD, ERBB2, ERBB3 and ERBB4. Heregulin (HRG) stimulates the interaction with ERBB2 and, to a much lesser extent, the interaction with ERBB3 and ERBB4. Interacts with P53 in response to DNA damage. Interacts with KLF4. Interacts with estrogen receptor alpha/ESR1, through its DNA-binding domain, and stimulates its transcription activity. Binds ADAM17. Isoform ZD forms disulfide-linked oligomers.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2804728">
<id>P15941</id>
</interactant>
<interactant intactId="EBI-375543">
<id>P00519</id>
<label>ABL1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2804728">
<id>P15941</id>
</interactant>
<interactant intactId="EBI-297353">
<id>P00533</id>
<label>EGFR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2804728">
<id>P15941</id>
</interactant>
<interactant intactId="EBI-1039152">
<id>P08581</id>
<label>MET</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2804728">
<id>P15941</id>
</interactant>
<interactant intactId="EBI-4396776">
<id>P15941-7</id>
<label>MUC1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2804728">
<id>P15941</id>
</interactant>
<interactant intactId="EBI-742339">
<id>P26368</id>
<label>U2AF2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-10225815">
<id>Q08AM2</id>
<label>ADAM33</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-2682765">
<id>O60242</id>
<label>ADGRB3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-10827839">
<id>Q15848</id>
<label>ADIPOQ</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-12109402">
<id>Q86W74-2</id>
<label>ANKRD46</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-1171525">
<id>P02652</id>
<label>APOA2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-17264467">
<id>P05067-2</id>
<label>APP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-745213">
<id>P29972</id>
<label>AQP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-12701138">
<id>P41181</id>
<label>AQP2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-2808854">
<id>Q92482</id>
<label>AQP3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-11724186">
<id>Q9H2C2</id>
<label>ARV1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-707714">
<id>Q92843</id>
<label>BCL2L2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-12244618">
<id>Q6PL45-2</id>
<label>BRICD5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-8648738">
<id>Q8WVV5</id>
<label>BTN2A2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-2835920">
<id>P06681</id>
<label>C2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-12822627">
<id>O14523</id>
<label>C2CD2L</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-9686780">
<id>Q06432</id>
<label>CACNG1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-9083477">
<id>Q9P0B6</id>
<label>CCDC167</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-17263290">
<id>Q08722-3</id>
<label>CD47</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-6657396">
<id>P19397</id>
<label>CD53</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-2826276">
<id>P34810</id>
<label>CD68</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-12256978">
<id>Q8N6F1-2</id>
<label>CLDN19</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-12955011">
<id>P56747</id>
<label>CLDN6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-11959453">
<id>Q8NHS1</id>
<label>CLDND2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-2807956">
<id>Q96FZ5</id>
<label>CMTM7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-10241815">
<id>Q4VAQ0</id>
<label>COL8A2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-10267100">
<id>Q8N6G5</id>
<label>CSGALNACT2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-3911467">
<id>Q07325</id>
<label>CXCL9</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-1058710">
<id>O43169</id>
<label>CYB5B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-1752413">
<id>P78329</id>
<label>CYP4F2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-10215665">
<id>P56851</id>
<label>EDDM3B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-2820492">
<id>Q9BV81</id>
<label>EMC6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-3907816">
<id>P54852</id>
<label>EMP3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-12279764">
<id>O75355-2</id>
<label>ENTPD3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-711490">
<id>Q9UKR5</id>
<label>ERG28</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-3436637">
<id>P01350</id>
<label>GAST</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-12702062">
<id>P39905-3</id>
<label>GDNF</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-4402607">
<id>Q9Y3E0</id>
<label>GOLT1B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-11343451">
<id>Q9NPR9</id>
<label>GPR108</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-5916693">
<id>Q9HCP6</id>
<label>HHATL</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-11721771">
<id>O60725</id>
<label>ICMT</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-8503746">
<id>Q9Y5U4</id>
<label>INSIG2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-2568251">
<id>P11215</id>
<label>ITGAM</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-944295">
<id>Q969L2</id>
<label>MAL2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-750078">
<id>Q13021</id>
<label>MALL</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-10317612">
<id>Q9P0N8</id>
<label>MARCHF2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-3920969">
<id>Q6N075</id>
<label>MFSD5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-8449636">
<id>P30301</id>
<label>MIP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-13301517">
<id>Q96S97</id>
<label>MYADM</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-1246131">
<id>O95167</id>
<label>NDUFA3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-721517">
<id>Q99519</id>
<label>NEU1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-2802124">
<id>Q92982</id>
<label>NINJ1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-10317425">
<id>Q9NZG7</id>
<label>NINJ2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-3919611">
<id>Q16617</id>
<label>NKG7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-12051377">
<id>Q8N912</id>
<label>NRAC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-13339917">
<id>Q8NH19</id>
<label>OR10AG1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-17265310">
<id>Q6TCH4</id>
<label>PAQR6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-692836">
<id>P26678</id>
<label>PLN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-12188331">
<id>P60201-2</id>
<label>PLP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-11721828">
<id>Q8IY26</id>
<label>PLPP6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-8652812">
<id>P54315</id>
<label>PNLIPRP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-14210385">
<id>Q59EV6</id>
<label>PPGB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-5544229">
<id>P30405</id>
<label>PPIF</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-6269616">
<id>Q96AA3</id>
<label>RFT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-17249212">
<id>Q02161-2</id>
<label>RHD</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-2695784">
<id>Q8TAC9</id>
<label>SCAMP5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-9679163">
<id>Q9Y6D0</id>
<label>SELENOK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-749270">
<id>Q8N6R1</id>
<label>SERP2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-10197617">
<id>P11686</id>
<label>SFTPC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-10262251">
<id>Q8IWU4</id>
<label>SLC30A8</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-10281213">
<id>Q969S0</id>
<label>SLC35B4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-12867720">
<id>Q6ICL7</id>
<label>SLC35E4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-10314552">
<id>Q9NVC3</id>
<label>SLC38A7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-8640191">
<id>Q9NRQ5</id>
<label>SMCO4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-12188413">
<id>B2RUZ4</id>
<label>SMIM1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-2877718">
<id>Q9NZ01</id>
<label>TECR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-941422">
<id>P07204</id>
<label>THBD</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-13082040">
<id>Q9BZW4</id>
<label>TM6SF2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-723946">
<id>P17152</id>
<label>TMEM11</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-10171534">
<id>A0PK00</id>
<label>TMEM120B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-12155101">
<id>Q9BTD3</id>
<label>TMEM121</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-10694905">
<id>Q5BJH2-2</id>
<label>TMEM128</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-348587">
<id>Q9BVK8</id>
<label>TMEM147</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-2800360">
<id>Q9Y6G1</id>
<label>TMEM14A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-2339195">
<id>Q9P0S9</id>
<label>TMEM14C</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-13046724">
<id>Q14656</id>
<label>TMEM187</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-12195227">
<id>Q8NBD8</id>
<label>TMEM229B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-12887458">
<id>Q9BU79</id>
<label>TMEM243</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-12015604">
<id>Q8N2M4</id>
<label>TMEM86A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-2548832">
<id>Q8N661</id>
<label>TMEM86B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-12111910">
<id>Q5BJF2</id>
<label>TMEM97</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-7333781">
<id>Q9Y2Y6</id>
<label>TMEM98</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-518882">
<id>O14763</id>
<label>TNFRSF10B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-11996766">
<id>Q8N609</id>
<label>TRAM1L1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-10243654">
<id>Q5BVD1</id>
<label>TTMP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-7601760">
<id>Q53HI1</id>
<label>UNC50</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-10191195">
<id>O95183</id>
<label>VAMP5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-6256462">
<id>Q9BQB6</id>
<label>VKORC1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17263240">
<id>P15941-11</id>
</interactant>
<interactant intactId="EBI-2849773">
<id>Q8IVQ6</id>
<label>ZDHHC21</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-10053698">
<id>PRO_0000317447</id>
</interactant>
<interactant intactId="EBI-969696">
<id>P17676</id>
<label>CEBPB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="7 16 17 20 24 28 31 32">Apical cell membrane</location>
<topology evidence="7 16 17 20 24 28 31 32">Single-pass type I membrane protein</topology>
</subcellularLocation>
<text>Exclusively located in the apical domain of the plasma membrane of highly polarized epithelial cells. After endocytosis, internalized and recycled to the cell membrane. Located to microvilli and to the tips of long filopodial protusions.</text>
</comment>
<comment type="subcellular location">
<molecule>Isoform 5</molecule>
<subcellularLocation>
<location>Secreted</location>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<molecule>Isoform Y</molecule>
<subcellularLocation>
<location>Secreted</location>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<molecule>Isoform 9</molecule>
<subcellularLocation>
<location>Secreted</location>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<molecule>Mucin-1 subunit beta</molecule>
<subcellularLocation>
<location>Cell membrane</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<text>On EGF and PDGFRB stimulation, transported to the nucleus through interaction with CTNNB1, a process which is stimulated by phosphorylation. On HRG stimulation, colocalizes with JUP/gamma-catenin at the nucleus.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P15941-1</id>
<name>1</name>
<name>A</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P15941-2</id>
<name>2</name>
<name>B</name>
<sequence type="described" ref="VSP_003280"/>
</isoform>
<isoform>
<id>P15941-3</id>
<name>3</name>
<name>C</name>
<sequence type="described" ref="VSP_003281"/>
</isoform>
<isoform>
<id>P15941-4</id>
<name>4</name>
<name>D</name>
<sequence type="described" ref="VSP_003282"/>
</isoform>
<isoform>
<id>P15941-5</id>
<name>5</name>
<name>SEC</name>
<sequence type="described" ref="VSP_003288 VSP_003289"/>
</isoform>
<isoform>
<id>P15941-6</id>
<name>6</name>
<name>X</name>
<sequence type="described" ref="VSP_003283 VSP_003284"/>
</isoform>
<isoform>
<id>P15941-7</id>
<name>Y</name>
<name>MUC1/Y</name>
<sequence type="described" ref="VSP_003285"/>
</isoform>
<isoform>
<id>P15941-8</id>
<name>8</name>
<name>Z</name>
<sequence type="described" ref="VSP_003286"/>
</isoform>
<isoform>
<id>P15941-9</id>
<name>9</name>
<name>S</name>
<sequence type="described" ref="VSP_003286 VSP_003287"/>
</isoform>
<isoform>
<id>P15941-10</id>
<name>F</name>
<sequence type="described" ref="VSP_035046 VSP_035047"/>
</isoform>
<isoform>
<id>P15941-11</id>
<name>Y-LSP</name>
<sequence type="described" ref="VSP_003280 VSP_003285"/>
</isoform>
<isoform>
<id>P15941-12</id>
<name>S2</name>
<sequence type="described" ref="VSP_003280 VSP_003285 VSP_003287"/>
</isoform>
<isoform>
<id>P15941-13</id>
<name>M6</name>
<sequence type="described" ref="VSP_003286 VSP_046962 VSP_046963"/>
</isoform>
<isoform>
<id>P15941-14</id>
<name>ZD</name>
<name>J19</name>
<sequence type="described" ref="VSP_047575 VSP_047576"/>
</isoform>
<isoform>
<id>P15941-15</id>
<name>T10</name>
<sequence type="described" ref="VSP_003280 VSP_047873"/>
</isoform>
<isoform>
<id>P15941-16</id>
<name>E2</name>
<sequence type="described" ref="VSP_003280 VSP_047872"/>
</isoform>
<isoform>
<id>P15941-17</id>
<name>J13</name>
<sequence type="described" ref="VSP_003280 VSP_003285 VSP_047874"/>
</isoform>
<text>Additional isoforms seem to exist.</text>
</comment>
<comment type="tissue specificity">
<text evidence="21 40">Expressed on the apical surface of epithelial cells, especially of airway passages, breast and uterus. Also expressed in activated and unactivated T-cells. Overexpressed in epithelial tumors, such as breast or ovarian cancer and also in non-epithelial tumor cells. Isoform Y is expressed in tumor cells only.</text>
</comment>
<comment type="developmental stage">
<text evidence="42">During fetal development, expressed at low levels in the colonic epithelium from 13 weeks of gestation.</text>
</comment>
<comment type="PTM">
<text evidence="6 37 41 43">Highly glycosylated (N- and O-linked carbohydrates and sialic acid). O-glycosylated to a varying degree on serine and threonine residues within each tandem repeat, ranging from mono- to penta-glycosylation. The average density ranges from about 50% in human milk to over 90% in T47D breast cancer cells. Further sialylation occurs during recycling. Membrane-shed glycoproteins from kidney and breast cancer cells have preferentially sialyated core 1 structures, while secreted forms from the same tissues display mainly core 2 structures. The O-glycosylated content is overlapping in both these tissues with terminal fucose and galactose, 2- and 3-linked galactose, 3- and 3,6-linked GalNAc-ol and 4-linked GlcNAc predominating. Differentially O-glycosylated in breast carcinomas with 3,4-linked GlcNAc. N-glycosylation consists of high-mannose, acidic complex-type and hybrid glycans in the secreted form MUC1/SEC, and neutral complex-type in the transmembrane form, MUC1/TM.</text>
</comment>
<comment type="PTM">
<text evidence="10 14 25">Proteolytic cleavage in the SEA domain occurs in the endoplasmic reticulum by an autoproteolytic mechanism and requires the full-length SEA domain as well as requiring a Ser, Thr or Cys residue at the P + 1 site. Cleavage at this site also occurs on isoform MUC1/X but not on isoform MUC1/Y. Ectodomain shedding is mediated by ADAM17.</text>
</comment>
<comment type="PTM">
<text evidence="28">Dual palmitoylation on cysteine residues in the CQC motif is required for recycling from endosomes back to the plasma membrane.</text>
</comment>
<comment type="PTM">
<text evidence="8 12 13 15 18 21 26 32 36 38 44">Phosphorylated on tyrosines and serine residues in the C-terminal. Phosphorylation on tyrosines in the C-terminal increases the nuclear location of MUC1 and beta-catenin. Phosphorylation by PKC delta induces binding of MUC1 to beta-catenin/CTNNB1 and thus decreases the formation of the beta-catenin/E-cadherin complex. Src-mediated phosphorylation inhibits interaction with GSK3B. Src- and EGFR-mediated phosphorylation on Tyr-1229 increases binding to beta-catenin/CTNNB1. GSK3B-mediated phosphorylation on Ser-1227 decreases this interaction but restores the formation of the beta-cadherin/E-cadherin complex. On T-cell receptor activation, phosphorylated by LCK. PDGFR-mediated phosphorylation increases nuclear colocalization of MUC1CT and CTNNB1.</text>
</comment>
<comment type="PTM">
<text evidence="10">The N-terminal sequence has been shown to begin at position 24 or 28.</text>
</comment>
<comment type="polymorphism">
<text>The number of repeats is highly polymorphic. It varies from 21 to 125 in the northern European population. The most frequent alleles contains 41 and 85 repeats. The tandemly repeated icosapeptide underlies polymorphism at three positions: PAPGSTAP[PAQT]AHGVTSAP[DT/ES]R, DT -&gt; ES and the single replacements P -&gt; A, P -&gt; Q and P-&gt; T. The most frequent replacement DT -&gt; ES occurs in up to 50% of the repeats.</text>
</comment>
<comment type="disease">
<text evidence="33">MUC1/CA 15-3 is used as a serological clinical marker of breast cancer to monitor response to breast cancer treatment and disease recurrence (PubMed:20816948). Decreased levels over time may be indicative of a positive response to treatment. Conversely, increased levels may indicate disease progression. At an early stage disease, only 21% of patients exhibit high MUC1/CA 15-3 levels, that is why CA 15-3 is not a useful screening test. Most antibodies target the highly immunodominant core peptide domain of 20 amino acid (APDTRPAPGSTAPPAHGVTS) tandem repeats. Some antibodies recognize glycosylated epitopes.</text>
</comment>
<comment type="disease" evidence="35">
<disease id="DI-03826">
<name>Medullary cystic kidney disease 1</name>
<acronym>MCKD1</acronym>
<description>A form of tubulointerstitial nephropathy characterized by formation of renal cysts at the corticomedullary junction. It is characterized by adult onset of impaired renal function and salt wasting resulting in end-stage renal failure by the sixth decade.</description>
<dbReference type="MIM" id="174000"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="miscellaneous">
<text>The name KL-6 was originally that of a murine monoclonal antibody reacting with pulmonary adenocarcinoma cell lines and pulmonary epithelial cells. This antibody recognizes a sialylated carbohydrate chain on MUC1.</text>
</comment>
<comment type="miscellaneous">
<molecule>Isoform Y-LSP</molecule>
<text evidence="61">Lacks the mucin repeats.</text>
</comment>
<comment type="miscellaneous">
<molecule>Isoform ZD</molecule>
<text evidence="61">Lacks the mucin repeats. Exists as a disulfide-linked oligomer.</text>
</comment>
<comment type="caution">
<text evidence="62 63">O-glycosylation sites are annotated in first sequence repeat only. Residues at similar position are probably glycosylated in all repeats. Experimental sites were determined in a synthetic peptide glycosylated in vitro (PubMed:7744025, PubMed:9597769).</text>
</comment>
<comment type="sequence caution" evidence="61">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="AAD14369" version="1"/>
</conflict>
<text>Extended N-terminus.</text>
</comment>
<comment type="sequence caution" evidence="61">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="AAD14376" version="1"/>
</conflict>
<text>Extended N-terminus.</text>
</comment>
<comment type="online information" name="Mucin database">
<link uri="http://www.medkem.gu.se/mucinbiology/databases/"/>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/muc1/"/>
</comment>
<dbReference type="EMBL" id="J05582">
<property type="protein sequence ID" value="AAA60019.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M32738">
<property type="protein sequence ID" value="AAA35804.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M32739">
<property type="protein sequence ID" value="AAA35806.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M34089">
<property type="protein sequence ID" value="AAA35807.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M34088">
<property type="protein sequence ID" value="AAA35805.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="J05581">
<property type="protein sequence ID" value="AAA59876.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M61170">
<property type="protein sequence ID" value="AAB53150.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X52229">
<property type="protein sequence ID" value="CAA36478.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X52228">
<property type="protein sequence ID" value="CAA36477.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M35093">
<property type="protein sequence ID" value="AAB59612.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X80761">
<property type="protein sequence ID" value="CAA56734.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U60259">
<property type="protein sequence ID" value="AAD10856.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U60260">
<property type="protein sequence ID" value="AAD10857.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U60261">
<property type="protein sequence ID" value="AAD10858.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF125525">
<property type="protein sequence ID" value="AAD27842.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY466157">
<property type="protein sequence ID" value="AAR28764.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY327582">
<property type="protein sequence ID" value="AAP97013.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY327584">
<property type="protein sequence ID" value="AAP97015.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY327586">
<property type="protein sequence ID" value="AAP97017.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY327587">
<property type="protein sequence ID" value="AAP97018.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="EF583653">
<property type="protein sequence ID" value="ABQ59628.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="EF670711">
<property type="protein sequence ID" value="ABS01298.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="EF670712">
<property type="protein sequence ID" value="ABS01299.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="FJ226040">
<property type="protein sequence ID" value="ACI25172.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="FJ226047">
<property type="protein sequence ID" value="ACI25179.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF348143">
<property type="protein sequence ID" value="AAK30142.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY463543">
<property type="protein sequence ID" value="AAR18816.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL713999">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471121">
<property type="protein sequence ID" value="EAW53116.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471121">
<property type="protein sequence ID" value="EAW53117.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471121">
<property type="protein sequence ID" value="EAW53118.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471121">
<property type="protein sequence ID" value="EAW53119.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC120974">
<property type="protein sequence ID" value="AAI20975.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC120975">
<property type="protein sequence ID" value="AAI20976.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="Z17324">
<property type="protein sequence ID" value="CAA78972.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="Z17325">
<property type="protein sequence ID" value="CAA78973.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M31823">
<property type="protein sequence ID" value="AAA35757.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="S81781">
<property type="protein sequence ID" value="AAD14376.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="S81736">
<property type="protein sequence ID" value="AAD14369.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M21868">
<property type="protein sequence ID" value="AAA59874.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS1098.1">
<molecule id="P15941-8"/>
</dbReference>
<dbReference type="CCDS" id="CCDS30882.1">
<molecule id="P15941-11"/>
</dbReference>
<dbReference type="CCDS" id="CCDS30883.1">
<molecule id="P15941-7"/>
</dbReference>
<dbReference type="CCDS" id="CCDS41408.1">
<molecule id="P15941-12"/>
</dbReference>
<dbReference type="CCDS" id="CCDS41409.1">
<molecule id="P15941-10"/>
</dbReference>
<dbReference type="CCDS" id="CCDS55641.1">
<molecule id="P15941-6"/>
</dbReference>
<dbReference type="CCDS" id="CCDS55642.1">
<molecule id="P15941-13"/>
</dbReference>
<dbReference type="PIR" id="A35175">
<property type="entry name" value="A35175"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001018016.1">
<molecule id="P15941-11"/>
<property type="nucleotide sequence ID" value="NM_001018016.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001018017.1">
<molecule id="P15941-7"/>
<property type="nucleotide sequence ID" value="NM_001018017.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001037855.1">
<molecule id="P15941-10"/>
<property type="nucleotide sequence ID" value="NM_001044390.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001037856.1">
<property type="nucleotide sequence ID" value="NM_001044391.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001037857.1">
<molecule id="P15941-12"/>
<property type="nucleotide sequence ID" value="NM_001044392.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001037858.1">
<property type="nucleotide sequence ID" value="NM_001044393.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001191214.1">
<property type="nucleotide sequence ID" value="NM_001204285.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001191215.1">
<property type="nucleotide sequence ID" value="NM_001204286.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001191216.1">
<property type="nucleotide sequence ID" value="NM_001204287.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001191217.1">
<property type="nucleotide sequence ID" value="NM_001204288.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001191218.1">
<property type="nucleotide sequence ID" value="NM_001204289.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001191219.1">
<property type="nucleotide sequence ID" value="NM_001204290.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001191220.1">
<property type="nucleotide sequence ID" value="NM_001204291.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001191221.1">
<property type="nucleotide sequence ID" value="NM_001204292.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001191222.1">
<molecule id="P15941-13"/>
<property type="nucleotide sequence ID" value="NM_001204293.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001191223.1">
<molecule id="P15941-6"/>
<property type="nucleotide sequence ID" value="NM_001204294.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001191224.1">
<property type="nucleotide sequence ID" value="NM_001204295.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001191225.1">
<property type="nucleotide sequence ID" value="NM_001204296.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001191226.1">
<property type="nucleotide sequence ID" value="NM_001204297.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_002447.4">
<molecule id="P15941-8"/>
<property type="nucleotide sequence ID" value="NM_002456.5"/>
</dbReference>
<dbReference type="PDB" id="1SM3">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.95"/>
<property type="chains" value="P=919-931"/>
</dbReference>
<dbReference type="PDB" id="2ACM">
<property type="method" value="NMR"/>
<property type="chains" value="A=1042-1097, B=1098-1152"/>
</dbReference>
<dbReference type="PDB" id="2FO4">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="P=140-146"/>
</dbReference>
<dbReference type="PDB" id="5T6P">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.97"/>
<property type="chains" value="E/F=921-928"/>
</dbReference>
<dbReference type="PDB" id="5T78">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="E/F=921-928"/>
</dbReference>
<dbReference type="PDB" id="6FZQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="P=921-926"/>
</dbReference>
<dbReference type="PDB" id="6FZR">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="P=921-926"/>
</dbReference>
<dbReference type="PDB" id="6TGG">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="P=921-926"/>
</dbReference>
<dbReference type="PDBsum" id="1SM3"/>
<dbReference type="PDBsum" id="2ACM"/>
<dbReference type="PDBsum" id="2FO4"/>
<dbReference type="PDBsum" id="5T6P"/>
<dbReference type="PDBsum" id="5T78"/>
<dbReference type="PDBsum" id="6FZQ"/>
<dbReference type="PDBsum" id="6FZR"/>
<dbReference type="PDBsum" id="6TGG"/>
<dbReference type="SMR" id="P15941"/>
<dbReference type="BioGRID" id="110669">
<property type="interactions" value="147"/>
</dbReference>
<dbReference type="DIP" id="DIP-41890N"/>
<dbReference type="IntAct" id="P15941">
<property type="interactions" value="121"/>
</dbReference>
<dbReference type="MINT" id="P15941"/>
<dbReference type="STRING" id="9606.ENSP00000484824"/>
<dbReference type="ChEMBL" id="CHEMBL3580494"/>
<dbReference type="DrugBank" id="DB11090">
<property type="generic name" value="Potassium nitrate"/>
</dbReference>
<dbReference type="DrugBank" id="DB06584">
<property type="generic name" value="TG4010"/>
</dbReference>
<dbReference type="MEROPS" id="S71.001"/>
<dbReference type="GlyConnect" id="372">
<property type="glycosylation" value="9 O-Linked glycans"/>
</dbReference>
<dbReference type="GlyConnect" id="373">
<property type="glycosylation" value="8 O-Linked glycans"/>
</dbReference>
<dbReference type="GlyConnect" id="374">
<property type="glycosylation" value="8 O-Linked glycans"/>
</dbReference>
<dbReference type="GlyConnect" id="375">
<property type="glycosylation" value="10 O-Linked glycans"/>
</dbReference>
<dbReference type="GlyConnect" id="376">
<property type="glycosylation" value="10 O-Linked glycans"/>
</dbReference>
<dbReference type="GlyConnect" id="377">
<property type="glycosylation" value="7 O-Linked glycans"/>
</dbReference>
<dbReference type="GlyConnect" id="413">
<property type="glycosylation" value="5 N-Linked glycans (1 site), 14 O-Linked glycans"/>
</dbReference>
<dbReference type="GlyGen" id="P15941">
<property type="glycosylation" value="13 sites, 5 O-linked glycans (4 sites)"/>
</dbReference>
<dbReference type="iPTMnet" id="P15941"/>
<dbReference type="PhosphoSitePlus" id="P15941"/>
<dbReference type="SwissPalm" id="P15941"/>
<dbReference type="UniCarbKB" id="P15941"/>
<dbReference type="BioMuta" id="MUC1"/>
<dbReference type="DMDM" id="296439295"/>
<dbReference type="CPTAC" id="CPTAC-146"/>
<dbReference type="CPTAC" id="CPTAC-147"/>
<dbReference type="CPTAC" id="CPTAC-719"/>
<dbReference type="CPTAC" id="CPTAC-730"/>
<dbReference type="jPOST" id="P15941"/>
<dbReference type="MassIVE" id="P15941"/>
<dbReference type="MaxQB" id="P15941"/>
<dbReference type="PaxDb" id="P15941"/>
<dbReference type="PeptideAtlas" id="P15941"/>
<dbReference type="PRIDE" id="P15941"/>
<dbReference type="ProteomicsDB" id="1779"/>
<dbReference type="ProteomicsDB" id="53249">
<molecule id="P15941-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="53250">
<molecule id="P15941-10"/>
</dbReference>
<dbReference type="ProteomicsDB" id="53251">
<molecule id="P15941-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="53252">
<molecule id="P15941-3"/>
</dbReference>
<dbReference type="ProteomicsDB" id="53253">
<molecule id="P15941-4"/>
</dbReference>
<dbReference type="ProteomicsDB" id="53254">
<molecule id="P15941-5"/>
</dbReference>
<dbReference type="ProteomicsDB" id="53255">
<molecule id="P15941-6"/>
</dbReference>
<dbReference type="ProteomicsDB" id="53256">
<molecule id="P15941-7"/>
</dbReference>
<dbReference type="ProteomicsDB" id="53257">
<molecule id="P15941-8"/>
</dbReference>
<dbReference type="ProteomicsDB" id="53258">
<molecule id="P15941-9"/>
</dbReference>
<dbReference type="ProteomicsDB" id="58806"/>
<dbReference type="ProteomicsDB" id="6245"/>
<dbReference type="ProteomicsDB" id="69255"/>
<dbReference type="ProteomicsDB" id="69256"/>
<dbReference type="ProteomicsDB" id="767"/>
<dbReference type="ABCD" id="P15941">
<property type="antibodies" value="33 sequenced antibodies"/>
</dbReference>
<dbReference type="Antibodypedia" id="1298">
<property type="antibodies" value="4452 antibodies"/>
</dbReference>
<dbReference type="CPTC" id="P15941">
<property type="antibodies" value="2 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="4582"/>
<dbReference type="Ensembl" id="ENST00000337604">
<molecule id="P15941-8"/>
<property type="protein sequence ID" value="ENSP00000338983"/>
<property type="gene ID" value="ENSG00000185499"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000342482">
<molecule id="P15941-16"/>
<property type="protein sequence ID" value="ENSP00000342814"/>
<property type="gene ID" value="ENSG00000185499"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000343256">
<molecule id="P15941-10"/>
<property type="protein sequence ID" value="ENSP00000339690"/>
<property type="gene ID" value="ENSG00000185499"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000368389">
<molecule id="P15941-9"/>
<property type="protein sequence ID" value="ENSP00000357374"/>
<property type="gene ID" value="ENSG00000185499"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000368390">
<molecule id="P15941-7"/>
<property type="protein sequence ID" value="ENSP00000357375"/>
<property type="gene ID" value="ENSG00000185499"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000368392">
<molecule id="P15941-11"/>
<property type="protein sequence ID" value="ENSP00000357377"/>
<property type="gene ID" value="ENSG00000185499"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000368393">
<molecule id="P15941-13"/>
<property type="protein sequence ID" value="ENSP00000357378"/>
<property type="gene ID" value="ENSG00000185499"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000368396">
<molecule id="P15941-12"/>
<property type="protein sequence ID" value="ENSP00000357381"/>
<property type="gene ID" value="ENSG00000185499"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000368398">
<molecule id="P15941-6"/>
<property type="protein sequence ID" value="ENSP00000357383"/>
<property type="gene ID" value="ENSG00000185499"/>
</dbReference>
<dbReference type="GeneID" id="4582"/>
<dbReference type="KEGG" id="hsa:4582"/>
<dbReference type="UCSC" id="uc001fia.4">
<molecule id="P15941-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="4582"/>
<dbReference type="DisGeNET" id="4582"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000185499.16"/>
<dbReference type="GeneCards" id="MUC1"/>
<dbReference type="GeneReviews" id="MUC1"/>
<dbReference type="HGNC" id="HGNC:7508">
<property type="gene designation" value="MUC1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000185499">
<property type="expression patterns" value="Tissue enhanced (gallbladder, kidney, lung)"/>
</dbReference>
<dbReference type="MalaCards" id="MUC1"/>
<dbReference type="MIM" id="113720">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="158340">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="174000">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P15941"/>
<dbReference type="OpenTargets" id="ENSG00000185499"/>
<dbReference type="Orphanet" id="88949">
<property type="disease" value="MUC1-related autosomal dominant tubulointerstitial kidney disease"/>
</dbReference>
<dbReference type="PharmGKB" id="PA31309"/>
<dbReference type="eggNOG" id="ENOG502QWCT">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00710000106874"/>
<dbReference type="HOGENOM" id="CLU_1386987_0_0_1"/>
<dbReference type="InParanoid" id="P15941"/>
<dbReference type="KO" id="K06568"/>
<dbReference type="OrthoDB" id="945460at2759"/>
<dbReference type="PhylomeDB" id="P15941"/>
<dbReference type="PathwayCommons" id="P15941"/>
<dbReference type="Reactome" id="R-HSA-5083625">
<property type="pathway name" value="Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5083632">
<property type="pathway name" value="Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5083636">
<property type="pathway name" value="Defective GALNT12 causes colorectal cancer 1 (CRCS1)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5621480">
<property type="pathway name" value="Dectin-2 family"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6785807">
<property type="pathway name" value="Interleukin-4 and Interleukin-13 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-913709">
<property type="pathway name" value="O-linked glycosylation of mucins"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-977068">
<property type="pathway name" value="Termination of O-glycan biosynthesis"/>
</dbReference>
<dbReference type="SIGNOR" id="P15941"/>
<dbReference type="BioGRID-ORCS" id="4582">
<property type="hits" value="5 hits in 876 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="MUC1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P15941"/>
<dbReference type="GeneWiki" id="MUC1"/>
<dbReference type="GenomeRNAi" id="4582"/>
<dbReference type="Pharos" id="P15941">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:P15941"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 1"/>
</dbReference>
<dbReference type="RNAct" id="P15941">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000185499">
<property type="expression patterns" value="Expressed in body of stomach and 212 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P15941">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P15941">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0016324">
<property type="term" value="C:apical plasma membrane"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005615">
<property type="term" value="C:extracellular space"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005796">
<property type="term" value="C:Golgi lumen"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0000790">
<property type="term" value="C:nuclear chromatin"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0031982">
<property type="term" value="C:vesicle"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002039">
<property type="term" value="F:p53 binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000978">
<property type="term" value="F:RNA polymerase II cis-regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003712">
<property type="term" value="F:transcription coregulator activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0019221">
<property type="term" value="P:cytokine-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006977">
<property type="term" value="P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006978">
<property type="term" value="P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0033629">
<property type="term" value="P:negative regulation of cell adhesion mediated by integrin"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CACAO"/>
</dbReference>
<dbReference type="GO" id="GO:1902166">
<property type="term" value="P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010944">
<property type="term" value="P:negative regulation of transcription by competitive promoter binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0016266">
<property type="term" value="P:O-glycan processing"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0090240">
<property type="term" value="P:positive regulation of histone H4 acetylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0036003">
<property type="term" value="P:positive regulation of transcription from RNA polymerase II promoter in response to stress"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043618">
<property type="term" value="P:regulation of transcription from RNA polymerase II promoter in response to stress"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0002223">
<property type="term" value="P:stimulatory C-type lectin receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="DisProt" id="DP01790"/>
<dbReference type="Gene3D" id="3.30.70.960">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="IDEAL" id="IID00195"/>
<dbReference type="InterPro" id="IPR023217">
<property type="entry name" value="Mucin-1"/>
</dbReference>
<dbReference type="InterPro" id="IPR000082">
<property type="entry name" value="SEA_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036364">
<property type="entry name" value="SEA_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR10006">
<property type="entry name" value="PTHR10006"/>
<property type="match status" value="7"/>
</dbReference>
<dbReference type="Pfam" id="PF01390">
<property type="entry name" value="SEA"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00200">
<property type="entry name" value="SEA"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF82671">
<property type="entry name" value="SSF82671"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50024">
<property type="entry name" value="SEA"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0068">Autocatalytic cleavage</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0449">Lipoprotein</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0564">Palmitate</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0964">Secreted</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0043">Tumor suppressor</keyword>
<feature type="signal peptide" evidence="6 10">
<location>
<begin position="1"/>
<end position="23"/>
</location>
</feature>
<feature type="chain" description="Mucin-1" id="PRO_0000019277">
<location>
<begin position="24"/>
<end position="1255"/>
</location>
</feature>
<feature type="chain" description="Mucin-1 subunit alpha" id="PRO_0000317446">
<location>
<begin position="24"/>
<end position="1097"/>
</location>
</feature>
<feature type="chain" description="Mucin-1 subunit beta" id="PRO_0000317447">
<location>
<begin position="1098"/>
<end position="1255"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="3">
<location>
<begin position="24"/>
<end position="1158"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="3">
<location>
<begin position="1159"/>
<end position="1181"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="3">
<location>
<begin position="1182"/>
<end position="1255"/>
</location>
</feature>
<feature type="repeat" description="1; approximate" evidence="11">
<location>
<begin position="61"/>
<end position="80"/>
</location>
</feature>
<feature type="repeat" description="2; approximate" evidence="11">
<location>
<begin position="81"/>
<end position="100"/>
</location>
</feature>
<feature type="repeat" description="3" evidence="11">
<location>
<begin position="101"/>
<end position="120"/>
</location>
</feature>
<feature type="repeat" description="4" evidence="11">
<location>
<begin position="121"/>
<end position="140"/>
</location>
</feature>
<feature type="repeat" description="5" evidence="11">
<location>
<begin position="141"/>
<end position="160"/>
</location>
</feature>
<feature type="repeat" description="6" evidence="11">
<location>
<begin position="161"/>
<end position="180"/>
</location>
</feature>
<feature type="repeat" description="7" evidence="11">
<location>
<begin position="181"/>
<end position="200"/>
</location>
</feature>
<feature type="repeat" description="8" evidence="11">
<location>
<begin position="201"/>
<end position="220"/>
</location>
</feature>
<feature type="repeat" description="9" evidence="11">
<location>
<begin position="221"/>
<end position="240"/>
</location>
</feature>
<feature type="repeat" description="10" evidence="11">
<location>
<begin position="241"/>
<end position="260"/>
</location>
</feature>
<feature type="repeat" description="11" evidence="11">
<location>
<begin position="261"/>
<end position="280"/>
</location>
</feature>
<feature type="repeat" description="12" evidence="11">
<location>
<begin position="281"/>
<end position="300"/>
</location>
</feature>
<feature type="repeat" description="13" evidence="11">
<location>
<begin position="301"/>
<end position="320"/>
</location>
</feature>
<feature type="repeat" description="14" evidence="11">
<location>
<begin position="321"/>
<end position="340"/>
</location>
</feature>
<feature type="repeat" description="15" evidence="11">
<location>
<begin position="341"/>
<end position="360"/>
</location>
</feature>
<feature type="repeat" description="16" evidence="11">
<location>
<begin position="361"/>
<end position="380"/>
</location>
</feature>
<feature type="repeat" description="17" evidence="11">
<location>
<begin position="381"/>
<end position="400"/>
</location>
</feature>
<feature type="repeat" description="18" evidence="11">
<location>
<begin position="401"/>
<end position="420"/>
</location>
</feature>
<feature type="repeat" description="19" evidence="11">
<location>
<begin position="421"/>
<end position="440"/>
</location>
</feature>
<feature type="repeat" description="20" evidence="11">
<location>
<begin position="441"/>
<end position="460"/>
</location>
</feature>
<feature type="repeat" description="21" evidence="11">
<location>
<begin position="461"/>
<end position="480"/>
</location>
</feature>
<feature type="repeat" description="22" evidence="11">
<location>
<begin position="481"/>
<end position="500"/>
</location>
</feature>
<feature type="repeat" description="23" evidence="11">
<location>
<begin position="501"/>
<end position="520"/>
</location>
</feature>
<feature type="repeat" description="24" evidence="11">
<location>
<begin position="521"/>
<end position="540"/>
</location>
</feature>
<feature type="repeat" description="25" evidence="11">
<location>
<begin position="541"/>
<end position="560"/>
</location>
</feature>
<feature type="repeat" description="26" evidence="11">
<location>
<begin position="561"/>
<end position="580"/>
</location>
</feature>
<feature type="repeat" description="27" evidence="11">
<location>
<begin position="581"/>
<end position="600"/>
</location>
</feature>
<feature type="repeat" description="28" evidence="11">
<location>
<begin position="601"/>
<end position="620"/>
</location>
</feature>
<feature type="repeat" description="29" evidence="11">
<location>
<begin position="621"/>
<end position="640"/>
</location>
</feature>
<feature type="repeat" description="30" evidence="11">
<location>
<begin position="641"/>
<end position="660"/>
</location>
</feature>
<feature type="repeat" description="31" evidence="11">
<location>
<begin position="661"/>
<end position="680"/>
</location>
</feature>
<feature type="repeat" description="32" evidence="11">
<location>
<begin position="681"/>
<end position="700"/>
</location>
</feature>
<feature type="repeat" description="33" evidence="11">
<location>
<begin position="701"/>
<end position="720"/>
</location>
</feature>
<feature type="repeat" description="34" evidence="11">
<location>
<begin position="721"/>
<end position="740"/>
</location>
</feature>
<feature type="repeat" description="35" evidence="11">
<location>
<begin position="741"/>
<end position="760"/>
</location>
</feature>
<feature type="repeat" description="36" evidence="11">
<location>
<begin position="761"/>
<end position="780"/>
</location>
</feature>
<feature type="repeat" description="37" evidence="11">
<location>
<begin position="781"/>
<end position="800"/>
</location>
</feature>
<feature type="repeat" description="38" evidence="11">
<location>
<begin position="801"/>
<end position="820"/>
</location>
</feature>
<feature type="repeat" description="39" evidence="11">
<location>
<begin position="821"/>
<end position="840"/>
</location>
</feature>
<feature type="repeat" description="40" evidence="11">
<location>
<begin position="841"/>
<end position="860"/>
</location>
</feature>
<feature type="repeat" description="41" evidence="11">
<location>
<begin position="861"/>
<end position="880"/>
</location>
</feature>
<feature type="repeat" description="42" evidence="11">
<location>
<begin position="881"/>
<end position="900"/>
</location>
</feature>
<feature type="repeat" description="43" evidence="11">
<location>
<begin position="901"/>
<end position="920"/>
</location>
</feature>
<feature type="repeat" description="44" evidence="11">
<location>
<begin position="921"/>
<end position="940"/>
</location>
</feature>
<feature type="repeat" description="45" evidence="11">
<location>
<begin position="941"/>
<end position="960"/>
</location>
</feature>
<feature type="repeat" description="46; approximate" evidence="11">
<location>
<begin position="961"/>
<end position="980"/>
</location>
</feature>
<feature type="repeat" description="47; approximate" evidence="11">
<location>
<begin position="981"/>
<end position="1000"/>
</location>
</feature>
<feature type="repeat" description="48; approximate" evidence="11">
<location>
<begin position="1001"/>
<end position="1020"/>
</location>
</feature>
<feature type="domain" description="SEA" evidence="4">
<location>
<begin position="1039"/>
<end position="1148"/>
</location>
</feature>
<feature type="region of interest" description="42 X 20 AA approximate tandem repeats of P-A-P-G-S-T-A-P-P-A-H-G-V-T-S-A-P-D-T-R">
<location>
<begin position="126"/>
<end position="965"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with P53">
<location>
<begin position="1192"/>
<end position="1228"/>
</location>
</feature>
<feature type="region of interest" description="Required for interaction with GSK3B">
<location>
<begin position="1223"/>
<end position="1230"/>
</location>
</feature>
<feature type="region of interest" description="Required for interaction with beta- and gamma-catenins">
<location>
<begin position="1233"/>
<end position="1241"/>
</location>
</feature>
<feature type="short sequence motif" description="Interaction with GRB2">
<location>
<begin position="1203"/>
<end position="1206"/>
</location>
</feature>
<feature type="short sequence motif" description="Interaction with SRC and ESR1">
<location>
<begin position="1229"/>
<end position="1232"/>
</location>
</feature>
<feature type="short sequence motif" description="Required for interaction with AP1S2">
<location>
<begin position="1243"/>
<end position="1246"/>
</location>
</feature>
<feature type="site" description="Cleavage; by autolysis">
<location>
<begin position="1097"/>
<end position="1098"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by PDGFR" evidence="18 32">
<location>
<position position="1203"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="18">
<location>
<position position="1212"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by PDGFR" evidence="32">
<location>
<position position="1218"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by PKC/PRKCD" evidence="13">
<location>
<position position="1224"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by GSK3-beta" evidence="2 44">
<location>
<position position="1227"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by CSK, EGFR and SRC" evidence="8 12 18 32">
<location>
<position position="1229"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="18">
<location>
<position position="1243"/>
</location>
</feature>
<feature type="lipid moiety-binding region" description="S-palmitoyl cysteine" evidence="28">
<location>
<position position="1184"/>
</location>
</feature>
<feature type="lipid moiety-binding region" description="S-palmitoyl cysteine" evidence="28">
<location>
<position position="1186"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (GalNAc...) threonine" evidence="62 63">
<location>
<position position="131"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (GalNAc...) threonine" evidence="62 63">
<location>
<position position="139"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (GalNAc...) serine" evidence="3">
<location>
<position position="140"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (GalNAc...) threonine" evidence="3">
<location>
<position position="144"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="957"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="975"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="1029"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="1055"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="1133"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_003281" evidence="60">
<location>
<begin position="19"/>
<end position="21"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2, isoform Y-LSP, isoform E2, isoform J13, isoform S2 and isoform T10." id="VSP_003280" evidence="46 49 50 52 54 58">
<original>T</original>
<variation>TATTAPKPAT</variation>
<location>
<position position="19"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_003282" evidence="60">
<location>
<begin position="20"/>
<end position="31"/>
</location>
</feature>
<feature type="splice variant" description="In isoform E2." id="VSP_047872" evidence="49">
<location>
<begin position="54"/>
<end position="1151"/>
</location>
</feature>
<feature type="splice variant" description="In isoform T10." id="VSP_047873" evidence="49">
<location>
<begin position="54"/>
<end position="1093"/>
</location>
</feature>
<feature type="splice variant" description="In isoform J13, isoform Y, isoform Y-LSP and isoform S2." id="VSP_003285" evidence="46 48 49 53 55 58">
<location>
<begin position="54"/>
<end position="1053"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 8, isoform 9 and isoform M6." id="VSP_003286" evidence="49 55 56 59">
<location>
<begin position="54"/>
<end position="1035"/>
</location>
</feature>
<feature type="splice variant" description="In isoform ZD." id="VSP_047575" evidence="47 49">
<original>VSMTSSVLSSHSPGSGSSTTQGQDVTLAPATEPASGSAATWGQ</original>
<variation>IPAPTTTKSCRETFLKCFCRFINKGVFWASPILSSGQDLWWYN</variation>
<location>
<begin position="54"/>
<end position="96"/>
</location>
</feature>
<feature type="splice variant" description="In isoform F." id="VSP_035046" evidence="57">
<original>VSMTSSVLSSHSPGSGSSTTQGQDVTLAPATEPA</original>
<variation>IPAPTTTKSCRETFLKCFCRFINKGVFWASPILS</variation>
<location>
<begin position="54"/>
<end position="87"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 6." id="VSP_003283" evidence="49 55">
<original>VSMTSSVLSSHSPGSGS</original>
<variation>IPAPTTTKSCRETFLKW</variation>
<location>
<begin position="54"/>
<end position="70"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 6." id="VSP_003284" evidence="49 55">
<location>
<begin position="71"/>
<end position="1095"/>
</location>
</feature>
<feature type="splice variant" description="In isoform F." id="VSP_035047" evidence="57">
<location>
<begin position="88"/>
<end position="1139"/>
</location>
</feature>
<feature type="splice variant" description="In isoform ZD." id="VSP_047576" evidence="47 49">
<location>
<begin position="97"/>
<end position="1255"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 9 and isoform S2." id="VSP_003287" evidence="49 56 58">
<location>
<begin position="1077"/>
<end position="1181"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 5." id="VSP_003288" evidence="51">
<original>FLQIYKQGGFL</original>
<variation>VSIGLSFPMLP</variation>
<location>
<begin position="1077"/>
<end position="1087"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 5." id="VSP_003289" evidence="51">
<location>
<begin position="1088"/>
<end position="1255"/>
</location>
</feature>
<feature type="splice variant" description="In isoform M6." id="VSP_046962" evidence="49 59">
<original>VSDVPFPFSAQSGAGVPGWGIALLVLVCVLVALAIVYLIA</original>
<variation>GCLSVPPKELRAAGHLSSPGYLPSYERVPHLPHPWALCAP</variation>
<location>
<begin position="1141"/>
<end position="1180"/>
</location>
</feature>
<feature type="splice variant" description="In isoform M6." id="VSP_046963" evidence="49 59">
<location>
<begin position="1181"/>
<end position="1255"/>
</location>
</feature>
<feature type="splice variant" description="In isoform J13." id="VSP_047874" evidence="49">
<original>VSAGNGGSSLSYTNPAVAATSANL</original>
<variation>RQNGWSTMPRGALPEESQG</variation>
<location>
<begin position="1232"/>
<end position="1255"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1611770." id="VAR_019390" evidence="23 34 45">
<original>V</original>
<variation>M</variation>
<location>
<position position="1117"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11465207." id="VAR_019391" evidence="45">
<original>S</original>
<variation>N</variation>
<location>
<position position="1142"/>
</location>
</feature>
<feature type="mutagenesis site" description="Completely abrogates cleavage." evidence="25">
<original>S</original>
<variation>A</variation>
<variation>D</variation>
<variation>E</variation>
<variation>F</variation>
<variation>G</variation>
<variation>H</variation>
<variation>I</variation>
<variation>K</variation>
<variation>L</variation>
<variation>M</variation>
<variation>N</variation>
<variation>P</variation>
<variation>Q</variation>
<variation>R</variation>
<variation>V</variation>
<variation>W</variation>
<variation>Y</variation>
<location>
<position position="1098"/>
</location>
</feature>
<feature type="mutagenesis site" description="Almost complete cleavage." evidence="25">
<original>S</original>
<variation>C</variation>
<variation>T</variation>
<location>
<position position="1098"/>
</location>
</feature>
<feature type="mutagenesis site" description="Greatly reduced formation of isoform 5/isoform Y complex." evidence="5">
<original>D</original>
<variation>A</variation>
<location>
<position position="1116"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on formation of isoform 5/isoform Y complex." evidence="5">
<original>D</original>
<variation>E</variation>
<location>
<position position="1116"/>
</location>
</feature>
<feature type="mutagenesis site" description="S-palmitoylation reduced by 50%. Complete loss of palmitoylation, no effect on endocytosis, recycling inhibited and AP1S1 binding reduced by 30%; when associated with C-1186. Accumulates in intracellular compartments; when associated with C-1186 and N-1203." evidence="28">
<original>C</original>
<variation>A</variation>
<location>
<position position="1184"/>
</location>
</feature>
<feature type="mutagenesis site" description="S-palmitoylation reduced by 50%. Complete loss of palmitoylation, no effect on endocytosis, recycling inhibited, and AP1S1 binding reduced by 30%; when associated with C-1184. Accumulates in intracellular compartments; when associated with C-1184 and N-1203." evidence="28">
<original>C</original>
<variation>A</variation>
<location>
<position position="1186"/>
</location>
</feature>
<feature type="mutagenesis site" description="No nuclear targeting of HRG-stimulated MUC1 C-terminal nor JUP/gamma-catenin. No effect on interaction with JUP/gamma-catenin." evidence="17 28">
<original>RRK</original>
<variation>AAA</variation>
<location>
<begin position="1187"/>
<end position="1189"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on palmitoylation." evidence="17 28">
<original>RRK</original>
<variation>QQQ</variation>
<location>
<begin position="1187"/>
<end position="1189"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on EGFR-mediated phosphorylation." evidence="12 20">
<original>Y</original>
<variation>F</variation>
<location>
<position position="1191"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on endocytosis." evidence="12 20">
<original>Y</original>
<variation>N</variation>
<location>
<position position="1191"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on nuclear colocalization of MUC1CT and CTNNB1. No effect on in vitro PDFGR-induced cell invasiveness." evidence="12 20 28 32">
<original>Y</original>
<variation>E</variation>
<location>
<position position="1203"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on EGFR-mediated phosphorylation. No nuclear localization of MUC1CT. Reduced in vitro PDGFR-induced cell invasiveness." evidence="12 20 28 32">
<original>Y</original>
<variation>F</variation>
<location>
<position position="1203"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced endocytosis by 30%. Greatly reduced binding to AP1S2 and GRB2. Binding AP1S1 reduced by 25%. Reduced endocytosis by 77%; when associated with N-1243. Accumulates in intracellular compartments; when associated with C-1184 and C-1186." evidence="12 20 28 32">
<original>Y</original>
<variation>N</variation>
<location>
<position position="1203"/>
</location>
</feature>
<feature type="mutagenesis site" description="Some reduction in EGFR-mediated phosphorylation." evidence="12">
<original>Y</original>
<variation>F</variation>
<location>
<position position="1209"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on EGFR-mediated phosphorylation. No nuclear colocalization of MUC1CT and CTNNB1." evidence="12 32">
<original>Y</original>
<variation>F</variation>
<location>
<position position="1218"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change in PRKCD- nor GSK3B-mediated phosphorylation." evidence="13 44">
<original>S</original>
<variation>A</variation>
<location>
<position position="1223"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of PRKCD-mediated phosphorylation. Decreased PRKCD binding. No increased binding to CTNNB1 in the presence of autophosphorylated PRKCD. Increases formation of E-cadherin/beta-catenin complex." evidence="13">
<original>T</original>
<variation>A</variation>
<location>
<position position="1224"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change in PRKCD-mediated phosphorylation. Loss of GSK3B-mediated phosphorylation. CTNNB1." evidence="13 44">
<original>S</original>
<variation>A</variation>
<location>
<position position="1227"/>
</location>
</feature>
<feature type="mutagenesis site" description="Greatly reduced EGFR- and Src-mediated phosphorylation. No nuclear localization of MUC1CT. Reduced in vitro PDGFR-mediated phosphorylation. Decreased Src-binding." evidence="8 12 19 20">
<original>Y</original>
<variation>F</variation>
<location>
<position position="1229"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on endocytosis." evidence="8 12 19 20">
<original>Y</original>
<variation>N</variation>
<location>
<position position="1229"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces binding to AP1S2 by 33%. Greatly reduced binding to GRB2. Reduced endocytosis by 50%. Reduced endocytosis by 77%; when associated with N-1203." evidence="20">
<original>Y</original>
<variation>N</variation>
<location>
<position position="1243"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 24; AAD14369." ref="24" evidence="61">
<original>T</original>
<variation>A</variation>
<location>
<position position="2"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 22; AAA35757." ref="22" evidence="61">
<original>P</original>
<variation>Q</variation>
<location>
<position position="134"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 22; AAA35757." ref="22" evidence="61">
<original>P</original>
<variation>Q</variation>
<location>
<position position="154"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAA35805/AAA35807 and 3; AAA59876." ref="2 3" evidence="61">
<original>S</original>
<variation>T</variation>
<location>
<position position="1021"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 11; AAP97018." ref="11" evidence="61">
<original>D</original>
<variation>G</variation>
<location>
<position position="1143"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 13; AAK30142." ref="13" evidence="61">
<original>Q</original>
<variation>L</variation>
<location>
<position position="1193"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 9; AAD10858." ref="9" evidence="61">
<original>K</original>
<variation>T</variation>
<location>
<position position="1231"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA60019." ref="1" evidence="61">
<original>T</original>
<variation>A</variation>
<location>
<position position="1251"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="1042"/>
<end position="1052"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="1056"/>
<end position="1059"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="1064"/>
<end position="1080"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="1082"/>
<end position="1085"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="1086"/>
<end position="1096"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="1099"/>
<end position="1107"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="1109"/>
<end position="1111"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="1114"/>
<end position="1132"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="1136"/>
<end position="1142"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2ACM"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000255"/>
<evidence key="4" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00188"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10197628"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10373415"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11118479"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11152665"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11173916"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11341784"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11350974"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11483589"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11877440"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12441351"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12750561"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12832415"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12939402"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14521915"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14688481"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15471854"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15513966"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15710329"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15969018"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15972891"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15987679"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16288032"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16427018"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16507569"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16983337"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17308127"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17524503"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17545600"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20816948"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22941036"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23396133"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7664271"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7744025"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7988707"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9139698"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9212228"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9312074"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9536947"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9597769"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9819408"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source ref="17"/>
</evidence>
<evidence key="46" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15623537"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15969018"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="22941036"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="2318825"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="2351132"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="2597151"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="7925397"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="8608966"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="9212228"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000303">
<source ref="12"/>
</evidence>
<evidence key="57" type="ECO:0000303">
<source ref="14"/>
</evidence>
<evidence key="58" type="ECO:0000303">
<source ref="15"/>
</evidence>
<evidence key="59" type="ECO:0000303">
<source ref="16"/>
</evidence>
<evidence key="60" type="ECO:0000303">
<source ref="25"/>
</evidence>
<evidence key="61" type="ECO:0000305"/>
<evidence key="62" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="7744025"/>
</source>
</evidence>
<evidence key="63" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="9597769"/>
</source>
</evidence>
<sequence length="1255" mass="122102" checksum="5E28DFC4C20D9A82" modified="2010-05-18" version="3" precursor="true">MTPGTQSPFFLLLLLTVLTVVTGSGHASSTPGGEKETSATQRSSVPSSTEKNAVSMTSSVLSSHSPGSGSSTTQGQDVTLAPATEPASGSAATWGQDVTSVPVTRPALGSTTPPAHDVTSAPDNKPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDNRPALGSTAPPVHNVTSASGSASGSASTLVHNGTSARATTTPASKSTPFSIPSHHSDTPTTLASHSTKTDASSTHHSSVPPLTSSNHSTSPQLSTGVSFFFLSFHISNLQFNSSLEDPSTDYYQELQRDISEMFLQIYKQGGFLGLSNIKFRPGSVVVQLTLAFREGTINVHDVETQFNQYKTEAASRYNLTISDVSVSDVPFPFSAQSGAGVPGWGIALLVLVCVLVALAIVYLIALAVCQCRRKNYGQLDIFPARDTYHPMSEYPTYHTHGRYVPPSSTDRSPYEKVSAGNGGSSLSYTNPAVAATSANL</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

